| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC6A18 CACNA1A GPR89B CACNA1C CHRNA6 ZACN CLCN6 NALCN KCNC3 ABCC8 PIEZO1 SLC22A3 SCN3A SCN4A GPR89A GRIA1 GRIA2 GRIA3 GRIA4 CACNA1H SLC5A8 KCNB2 MCOLN3 SLC5A1 TPCN1 SLC5A4 | 9.18e-20 | 793 | 66 | 26 | GO:0015075 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1A GPR89B CACNA1C CHRNA6 ZACN CLCN6 NALCN KCNC3 ABCC8 PIEZO1 SCN3A SCN4A GPR89A GRIA1 GRIA2 GRIA3 GRIA4 CACNA1H SLC5A8 KCNB2 MCOLN3 TPCN1 | 7.23e-19 | 526 | 66 | 22 | GO:0022803 |
| GeneOntologyMolecularFunction | transporter activity | SLC6A18 CACNA1A GPR89B CACNA1C CHRNA6 ZACN CLCN6 NALCN KCNC3 ABCC8 PIEZO1 SLC22A3 SCN3A SCN4A SLC19A2 GPR89A GRIA1 GRIA2 GRIA3 GRIA4 CACNA1H SLC35E3 SLC5A8 KCNB2 XKR4 SLC14A2 MCOLN3 SLC5A1 TPCN1 SLC5A4 | 8.23e-19 | 1289 | 66 | 30 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1A GPR89B CACNA1C CHRNA6 ZACN CLCN6 NALCN KCNC3 ABCC8 PIEZO1 SCN3A SCN4A GPR89A GRIA1 GRIA2 GRIA3 GRIA4 CACNA1H KCNB2 MCOLN3 TPCN1 | 8.50e-19 | 459 | 66 | 21 | GO:0005216 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC6A18 CACNA1A GPR89B CACNA1C CHRNA6 ZACN CLCN6 NALCN KCNC3 ABCC8 PIEZO1 SLC22A3 SCN3A SCN4A SLC19A2 GPR89A GRIA1 GRIA2 GRIA3 GRIA4 CACNA1H SLC35E3 SLC5A8 KCNB2 SLC14A2 MCOLN3 SLC5A1 TPCN1 SLC5A4 | 9.15e-19 | 1180 | 66 | 29 | GO:0022857 |
| GeneOntologyMolecularFunction | channel activity | CACNA1A GPR89B CACNA1C CHRNA6 ZACN CLCN6 NALCN KCNC3 ABCC8 PIEZO1 SCN3A SCN4A GPR89A GRIA1 GRIA2 GRIA3 GRIA4 CACNA1H KCNB2 MCOLN3 TPCN1 | 1.31e-17 | 525 | 66 | 21 | GO:0015267 |
| GeneOntologyMolecularFunction | gated channel activity | CACNA1A GPR89B CACNA1C CHRNA6 ZACN CLCN6 KCNC3 ABCC8 PIEZO1 GPR89A GRIA1 GRIA2 GRIA3 GRIA4 CACNA1H KCNB2 MCOLN3 TPCN1 | 2.20e-17 | 334 | 66 | 18 | GO:0022836 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC6A18 CACNA1A CACNA1C CHRNA6 ZACN NALCN KCNC3 ABCC8 PIEZO1 SLC22A3 SCN3A SCN4A GRIA1 GRIA2 GRIA3 CACNA1H SLC5A8 KCNB2 MCOLN3 SLC5A1 TPCN1 SLC5A4 | 9.90e-17 | 664 | 66 | 22 | GO:0008324 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC6A18 CACNA1A CACNA1C NALCN KCNC3 ABCC8 SLC22A3 SCN3A SCN4A GRIA1 GRIA2 GRIA3 CACNA1H SLC5A8 KCNB2 MCOLN3 SLC5A1 TPCN1 SLC5A4 | 4.14e-16 | 465 | 66 | 19 | GO:0046873 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1A CACNA1C CHRNA6 ZACN NALCN KCNC3 ABCC8 PIEZO1 SCN3A SCN4A GRIA1 GRIA2 GRIA3 CACNA1H KCNB2 MCOLN3 TPCN1 | 7.80e-16 | 343 | 66 | 17 | GO:0005261 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC6A18 CACNA1A CACNA1C NALCN KCNC3 ABCC8 SLC22A3 SCN3A SCN4A GRIA1 GRIA2 GRIA3 GRIA4 CACNA1H SLC5A8 KCNB2 MCOLN3 SLC5A1 TPCN1 SLC5A4 | 6.79e-15 | 627 | 66 | 20 | GO:0022890 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC6A18 CACNA1A CACNA1C CLCN6 NALCN KCNC3 ABCC8 SLC22A3 SCN3A SCN4A GRIA1 GRIA2 GRIA3 GRIA4 CACNA1H SLC5A8 KCNB2 MCOLN3 SLC5A1 TPCN1 SLC5A4 | 1.98e-14 | 758 | 66 | 21 | GO:0015318 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | SLC6A18 NALCN SLC22A3 SCN3A SCN4A GRIA2 CACNA1H SLC5A8 MCOLN3 SLC5A1 TPCN1 SLC5A4 | 3.48e-13 | 171 | 66 | 12 | GO:0015081 |
| GeneOntologyMolecularFunction | AMPA glutamate receptor activity | 1.09e-10 | 4 | 66 | 4 | GO:0004971 | |
| GeneOntologyMolecularFunction | sodium channel activity | 3.70e-10 | 52 | 66 | 7 | GO:0005272 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | CACNA1A GPR89B CACNA1C CLCN6 KCNC3 ABCC8 GPR89A CACNA1H KCNB2 TPCN1 | 4.66e-10 | 184 | 66 | 10 | GO:0022832 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR5D16 CHRNA6 ZACN ADRA2C HTR2C AVPR1B AVPR2 ABCC8 IL21R FSHR NTSR2 OR2W1 GRIA1 GRIA2 GRIA3 NMUR1 GRIA4 GCGR IL5RA OPRD1 | 7.27e-09 | 1353 | 66 | 20 | GO:0004888 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | CACNA1A GPR89B CACNA1C CLCN6 KCNC3 ABCC8 GPR89A CACNA1H KCNB2 | 8.43e-09 | 182 | 66 | 9 | GO:0005244 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.41e-08 | 193 | 66 | 9 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.68e-08 | 197 | 66 | 9 | GO:0022834 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 1.95e-08 | 140 | 66 | 8 | GO:0099094 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 2.11e-08 | 26 | 66 | 5 | GO:0005248 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 2.04e-07 | 77 | 66 | 6 | GO:0005230 | |
| GeneOntologyMolecularFunction | calcium channel activity | 2.26e-07 | 129 | 66 | 7 | GO:0005262 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 2.51e-07 | 17 | 66 | 4 | GO:0004970 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 2.79e-07 | 133 | 66 | 7 | GO:0008528 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 3.95e-07 | 140 | 66 | 7 | GO:0001653 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 6.59e-07 | 151 | 66 | 7 | GO:0015085 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 9.66e-07 | 100 | 66 | 6 | GO:0030594 | |
| GeneOntologyMolecularFunction | peptide binding | 9.82e-07 | 318 | 66 | 9 | GO:0042277 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 1.10e-06 | 24 | 66 | 4 | GO:0099507 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 1.24e-06 | 57 | 66 | 5 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 1.60e-06 | 60 | 66 | 5 | GO:0099529 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 1.80e-06 | 27 | 66 | 4 | GO:0008066 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 2.40e-06 | 65 | 66 | 5 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 2.40e-06 | 65 | 66 | 5 | GO:0022824 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 3.20e-06 | 31 | 66 | 4 | GO:0099604 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 4.88e-06 | 75 | 66 | 5 | GO:0098960 | |
| GeneOntologyMolecularFunction | amide binding | 6.22e-06 | 299 | 66 | 8 | GO:0033218 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 7.14e-06 | 81 | 66 | 5 | GO:0015370 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.06e-05 | 151 | 66 | 6 | GO:0008509 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 1.10e-05 | 152 | 66 | 6 | GO:0022843 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.22e-05 | 14 | 66 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 2.20e-05 | 102 | 66 | 5 | GO:0001540 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 2.27e-05 | 17 | 66 | 3 | GO:0008308 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 2.53e-05 | 105 | 66 | 5 | GO:0015171 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 4.62e-05 | 119 | 66 | 5 | GO:0015294 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 5.06e-05 | 293 | 66 | 7 | GO:0008514 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 5.40e-05 | 296 | 66 | 7 | GO:0015291 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 6.25e-05 | 207 | 66 | 6 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 6.42e-05 | 208 | 66 | 6 | GO:0005342 | |
| GeneOntologyMolecularFunction | potassium channel activity | 6.54e-05 | 128 | 66 | 5 | GO:0005267 | |
| GeneOntologyMolecularFunction | NAADP-sensitive calcium-release channel activity | 1.07e-04 | 5 | 66 | 2 | GO:0072345 | |
| GeneOntologyMolecularFunction | symporter activity | 1.38e-04 | 150 | 66 | 5 | GO:0015293 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR5D16 ADRA2C HTR2C AVPR1B AVPR2 FSHR NTSR2 OR2W1 NMUR1 GCGR OPRD1 | 1.39e-04 | 884 | 66 | 11 | GO:0004930 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 1.70e-04 | 477 | 66 | 8 | GO:0022804 | |
| GeneOntologyMolecularFunction | D-glucose:sodium symporter activity | 2.24e-04 | 7 | 66 | 2 | GO:0005412 | |
| GeneOntologyMolecularFunction | vasopressin receptor activity | 2.24e-04 | 7 | 66 | 2 | GO:0005000 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 2.28e-04 | 167 | 66 | 5 | GO:0015079 | |
| GeneOntologyMolecularFunction | glutamate-gated calcium ion channel activity | 2.97e-04 | 8 | 66 | 2 | GO:0022849 | |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 3.76e-04 | 103 | 66 | 4 | GO:0005253 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 4.73e-04 | 46 | 66 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 4.75e-04 | 301 | 66 | 6 | GO:0022853 | |
| GeneOntologyMolecularFunction | carbohydrate:monoatomic cation symporter activity | 1.42e-03 | 17 | 66 | 2 | GO:0005402 | |
| GeneOntologyMolecularFunction | sodium:chloride symporter activity | 1.42e-03 | 17 | 66 | 2 | GO:0015378 | |
| GeneOntologyMolecularFunction | ligand-gated sodium channel activity | 1.59e-03 | 18 | 66 | 2 | GO:0015280 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.59e-03 | 18 | 66 | 2 | GO:0015278 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 1.61e-03 | 70 | 66 | 3 | GO:1901618 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 1.77e-03 | 19 | 66 | 2 | GO:0015373 | |
| GeneOntologyMolecularFunction | myosin V binding | 1.97e-03 | 20 | 66 | 2 | GO:0031489 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 2.60e-03 | 23 | 66 | 2 | GO:0015377 | |
| GeneOntologyMolecularFunction | adrenergic receptor binding | 2.83e-03 | 24 | 66 | 2 | GO:0031690 | |
| GeneOntologyMolecularFunction | D-glucose transmembrane transporter activity | 3.07e-03 | 25 | 66 | 2 | GO:0055056 | |
| GeneOntologyMolecularFunction | hexose transmembrane transporter activity | 3.07e-03 | 25 | 66 | 2 | GO:0015149 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 3.32e-03 | 26 | 66 | 2 | GO:0015296 | |
| GeneOntologyMolecularFunction | monosaccharide transmembrane transporter activity | 3.58e-03 | 27 | 66 | 2 | GO:0015145 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 3.62e-03 | 93 | 66 | 3 | GO:0097110 | |
| GeneOntologyMolecularFunction | delayed rectifier potassium channel activity | 3.85e-03 | 28 | 66 | 2 | GO:0005251 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 4.12e-03 | 29 | 66 | 2 | GO:0051119 | |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity | 4.69e-03 | 102 | 66 | 3 | GO:0005249 | |
| GeneOntologyMolecularFunction | hormone binding | 4.82e-03 | 103 | 66 | 3 | GO:0042562 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 5.32e-03 | 33 | 66 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | immunoglobulin binding | 6.30e-03 | 36 | 66 | 2 | GO:0019865 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC6A18 CACNA1A GPR89B CACNA1C CHRNA6 ZACN HTR2C CLCN6 NALCN KCNC3 ABCC8 PIEZO1 SLC22A3 STIMATE SCN3A SCN4A GPR89A GRIA1 GRIA2 GRIA3 NMUR1 GRIA4 CACNA1H SLC5A8 KCNB2 MCOLN3 OPRD1 SLC5A1 TPCN1 SLC5A4 | 2.00e-18 | 1374 | 66 | 30 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC6A18 CACNA1A GPR89B CACNA1C CHRNA6 ZACN HTR2C CLCN6 NALCN KCNC3 ABCC8 PIEZO1 STIMATE SCN3A SCN4A GPR89A GRIA1 GRIA2 GRIA3 GRIA4 CACNA1H KCNB2 MCOLN3 SLC5A1 TPCN1 SLC5A4 | 1.76e-16 | 1115 | 66 | 26 | GO:0034220 |
| GeneOntologyBiologicalProcess | regulation of membrane potential | CACNA1A CACNA1C CHRNA6 NALCN KCNC3 ABCC8 PIEZO1 SCN3A SCN4A NTSR2 GRIA1 GRIA2 GRIA3 GRIA4 CACNA1H KCNB2 OPRD1 | 1.33e-12 | 559 | 66 | 17 | GO:0042391 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | SLC6A18 CACNA1A CACNA1C ZACN HTR2C NALCN KCNC3 ABCC8 PIEZO1 STIMATE SCN3A SCN4A GRIA2 CACNA1H SLC5A8 KCNB2 MCOLN3 OPRD1 SLC5A1 TPCN1 SLC5A4 | 3.53e-11 | 1157 | 66 | 21 | GO:0006812 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SLC6A18 CACNA1A CACNA1C ZACN HTR2C NALCN KCNC3 ABCC8 PIEZO1 STIMATE SCN3A SCN4A GRIA2 CACNA1H KCNB2 MCOLN3 SLC5A1 TPCN1 SLC5A4 | 6.45e-11 | 942 | 66 | 19 | GO:0098655 |
| GeneOntologyBiologicalProcess | metal ion transport | SLC6A18 CACNA1A CACNA1C HTR2C NALCN KCNC3 ABCC8 STIMATE SCN3A SCN4A CACNA1H SLC5A8 KCNB2 MCOLN3 OPRD1 SLC5A1 TPCN1 SLC5A4 | 1.42e-09 | 1000 | 66 | 18 | GO:0030001 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC6A18 CACNA1A CACNA1C HTR2C CLCN6 NALCN KCNC3 ABCC8 STIMATE SCN3A SCN4A CACNA1H SLC5A8 KCNB2 MCOLN3 SLC5A1 TPCN1 SLC5A4 | 1.85e-09 | 1017 | 66 | 18 | GO:0098660 |
| GeneOntologyBiologicalProcess | sodium ion transport | SLC6A18 NALCN SCN3A SCN4A CACNA1H SLC5A8 MCOLN3 SLC5A1 TPCN1 SLC5A4 | 1.65e-08 | 275 | 66 | 10 | GO:0006814 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | SLC6A18 NALCN SCN3A SCN4A CACNA1H MCOLN3 SLC5A1 TPCN1 SLC5A4 | 2.04e-08 | 208 | 66 | 9 | GO:0035725 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC6A18 CACNA1A CACNA1C HTR2C NALCN KCNC3 ABCC8 STIMATE SCN3A SCN4A CACNA1H KCNB2 MCOLN3 SLC5A1 TPCN1 SLC5A4 | 2.33e-08 | 922 | 66 | 16 | GO:0098662 |
| GeneOntologyBiologicalProcess | circulatory system process | ZDHHC21 CACNA1C ADRA2C HTR2C AVPR1B AVPR2 ABCC8 SLC22A3 SCN3A SCN4A FSHR CACNA1H GCGR SLC5A1 | 6.32e-08 | 733 | 66 | 14 | GO:0003013 |
| GeneOntologyBiologicalProcess | action potential | 2.50e-07 | 201 | 66 | 8 | GO:0001508 | |
| GeneOntologyBiologicalProcess | regulation of vasoconstriction | 7.11e-07 | 98 | 66 | 6 | GO:0019229 | |
| GeneOntologyBiologicalProcess | blood circulation | ZDHHC21 CACNA1C ADRA2C HTR2C AVPR1B AVPR2 ABCC8 SCN3A SCN4A FSHR CACNA1H GCGR | 8.71e-07 | 648 | 66 | 12 | GO:0008015 |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | ZDHHC21 CACNA1C ADRA2C HTR2C AVPR1B AVPR2 ABCC8 SLC22A3 SLC5A1 | 1.44e-06 | 344 | 66 | 9 | GO:0003018 |
| GeneOntologyBiologicalProcess | ionotropic glutamate receptor signaling pathway | 1.59e-06 | 27 | 66 | 4 | GO:0035235 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 1.93e-06 | 183 | 66 | 7 | GO:0006820 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 2.45e-06 | 121 | 66 | 6 | GO:0051899 | |
| GeneOntologyBiologicalProcess | vasoconstriction | 2.45e-06 | 121 | 66 | 6 | GO:0042310 | |
| GeneOntologyBiologicalProcess | synaptic transmission, glutamatergic | 4.06e-06 | 132 | 66 | 6 | GO:0035249 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 5.21e-06 | 36 | 66 | 4 | GO:0086010 | |
| GeneOntologyBiologicalProcess | import into cell | CACNA1A CACNA1C XKR7 KCNC3 ABCC8 SLC22A3 GRIA1 GRIA2 RAB39A CACNA1H XKR6 XKR4 SLC5A1 TPCN1 | 6.04e-06 | 1074 | 66 | 14 | GO:0098657 |
| GeneOntologyBiologicalProcess | phosphatidylserine exposure on apoptotic cell surface | 6.74e-06 | 12 | 66 | 3 | GO:0070782 | |
| GeneOntologyBiologicalProcess | organic cation transport | 6.99e-06 | 145 | 66 | 6 | GO:0015695 | |
| GeneOntologyBiologicalProcess | ligand-gated ion channel signaling pathway | 8.01e-06 | 40 | 66 | 4 | GO:1990806 | |
| GeneOntologyBiologicalProcess | synaptic transmission, cholinergic | 1.18e-05 | 44 | 66 | 4 | GO:0007271 | |
| GeneOntologyBiologicalProcess | engulfment of apoptotic cell | 1.39e-05 | 15 | 66 | 3 | GO:0043652 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, cholinergic | 2.06e-05 | 17 | 66 | 3 | GO:0032222 | |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | 2.23e-05 | 266 | 66 | 7 | GO:0019722 | |
| GeneOntologyBiologicalProcess | positive regulation of vasoconstriction | 2.68e-05 | 54 | 66 | 4 | GO:0045907 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 2.96e-05 | 112 | 66 | 5 | GO:0019226 | |
| GeneOntologyBiologicalProcess | calcium ion transport | CACNA1A CACNA1C HTR2C NALCN STIMATE CACNA1H MCOLN3 OPRD1 TPCN1 | 3.36e-05 | 509 | 66 | 9 | GO:0006816 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | CACNA1A CACNA1C CHRNA6 HTR2C NALCN KCNC3 CAMKV ABCC8 GRIA1 GRIA2 GRIA3 GRIA4 | 3.45e-05 | 931 | 66 | 12 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | CACNA1A CACNA1C CHRNA6 HTR2C NALCN KCNC3 CAMKV ABCC8 GRIA1 GRIA2 GRIA3 GRIA4 | 3.45e-05 | 931 | 66 | 12 | GO:0007268 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 3.48e-05 | 392 | 66 | 8 | GO:0070588 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | CACNA1A CACNA1C CHRNA6 HTR2C NALCN KCNC3 CAMKV ABCC8 GRIA1 GRIA2 GRIA3 GRIA4 | 3.75e-05 | 939 | 66 | 12 | GO:0099537 |
| GeneOntologyBiologicalProcess | glutamate receptor signaling pathway | 3.81e-05 | 59 | 66 | 4 | GO:0007215 | |
| GeneOntologyBiologicalProcess | regulation of muscle contraction | 4.56e-05 | 202 | 66 | 6 | GO:0006937 | |
| GeneOntologyBiologicalProcess | blood vessel diameter maintenance | 4.56e-05 | 202 | 66 | 6 | GO:0097746 | |
| GeneOntologyBiologicalProcess | regulation of tube diameter | 4.56e-05 | 202 | 66 | 6 | GO:0035296 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | CACNA1A CHRNA6 HTR2C NALCN KCNC3 CAMKV GRIA1 GRIA2 GRIA3 GRIA4 | 4.58e-05 | 663 | 66 | 10 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | CACNA1A CHRNA6 HTR2C NALCN KCNC3 CAMKV GRIA1 GRIA2 GRIA3 GRIA4 | 4.63e-05 | 664 | 66 | 10 | GO:0099177 |
| GeneOntologyBiologicalProcess | regulation of tube size | 4.69e-05 | 203 | 66 | 6 | GO:0035150 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 4.94e-05 | 63 | 66 | 4 | GO:0019228 | |
| GeneOntologyBiologicalProcess | synaptic signaling | CACNA1A CACNA1C CHRNA6 HTR2C NALCN KCNC3 CAMKV ABCC8 GRIA1 GRIA2 GRIA3 GRIA4 | 5.45e-05 | 976 | 66 | 12 | GO:0099536 |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled receptor signaling pathway | 6.74e-05 | 133 | 66 | 5 | GO:0007200 | |
| GeneOntologyBiologicalProcess | regulation of muscle system process | 6.79e-05 | 317 | 66 | 7 | GO:0090257 | |
| GeneOntologyBiologicalProcess | plasma membrane phospholipid scrambling | 7.72e-05 | 26 | 66 | 3 | GO:0017121 | |
| GeneOntologyBiologicalProcess | regulation of blood circulation | 8.09e-05 | 326 | 66 | 7 | GO:1903522 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 9.19e-05 | 142 | 66 | 5 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 9.19e-05 | 142 | 66 | 5 | GO:0098659 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by vasopressin | 1.00e-04 | 5 | 66 | 2 | GO:0001992 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission | 1.01e-04 | 233 | 66 | 6 | GO:0050806 | |
| GeneOntologyBiologicalProcess | regulation of system process | ZDHHC21 CACNA1C ADRA2C HTR2C AVPR1B AVPR2 ABCC8 SCN4A CACNA1H KCNB2 | 1.07e-04 | 734 | 66 | 10 | GO:0044057 |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 1.31e-04 | 153 | 66 | 5 | GO:0098656 | |
| GeneOntologyBiologicalProcess | regulation of receptor recycling | 1.32e-04 | 31 | 66 | 3 | GO:0001919 | |
| GeneOntologyBiologicalProcess | regulation of presynaptic membrane potential | 1.45e-04 | 32 | 66 | 3 | GO:0099505 | |
| GeneOntologyBiologicalProcess | neurotransmitter transport | 1.79e-04 | 259 | 66 | 6 | GO:0006836 | |
| GeneOntologyBiologicalProcess | regulation of acetylcholine secretion, neurotransmission | 2.10e-04 | 7 | 66 | 2 | GO:0014056 | |
| GeneOntologyBiologicalProcess | acetylcholine secretion, neurotransmission | 2.10e-04 | 7 | 66 | 2 | GO:0014055 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 2.25e-04 | 93 | 66 | 4 | GO:0086003 | |
| GeneOntologyBiologicalProcess | potassium ion transport | 2.33e-04 | 272 | 66 | 6 | GO:0006813 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 2.78e-04 | 180 | 66 | 5 | GO:0060078 | |
| GeneOntologyBiologicalProcess | acetylcholine secretion | 2.79e-04 | 8 | 66 | 2 | GO:0061526 | |
| GeneOntologyBiologicalProcess | positive regulation of adenylate cyclase activity | 2.84e-04 | 40 | 66 | 3 | GO:0045762 | |
| GeneOntologyBiologicalProcess | muscle contraction | 2.85e-04 | 400 | 66 | 7 | GO:0006936 | |
| GeneOntologyBiologicalProcess | locomotory behavior | 2.94e-04 | 284 | 66 | 6 | GO:0007626 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | 3.31e-04 | 410 | 66 | 7 | GO:0046942 | |
| GeneOntologyBiologicalProcess | organic acid transport | 3.40e-04 | 412 | 66 | 7 | GO:0015849 | |
| GeneOntologyBiologicalProcess | muscle system process | 3.46e-04 | 547 | 66 | 8 | GO:0003012 | |
| GeneOntologyBiologicalProcess | apoptotic process involved in development | 4.59e-04 | 47 | 66 | 3 | GO:1902742 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 4.88e-04 | 48 | 66 | 3 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 4.88e-04 | 48 | 66 | 3 | GO:1902656 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclase activity | 4.88e-04 | 48 | 66 | 3 | GO:0031281 | |
| GeneOntologyBiologicalProcess | apoptotic cell clearance | 4.88e-04 | 48 | 66 | 3 | GO:0043277 | |
| GeneOntologyBiologicalProcess | positive regulation of lyase activity | 5.19e-04 | 49 | 66 | 3 | GO:0051349 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission, cholinergic | 6.52e-04 | 12 | 66 | 2 | GO:0032224 | |
| GeneOntologyBiologicalProcess | acetylcholine transport | 6.52e-04 | 12 | 66 | 2 | GO:0015870 | |
| GeneOntologyBiologicalProcess | regulation of amine transport | 6.93e-04 | 125 | 66 | 4 | GO:0051952 | |
| GeneOntologyBiologicalProcess | phospholipid translocation | 7.29e-04 | 55 | 66 | 3 | GO:0045332 | |
| GeneOntologyBiologicalProcess | receptor recycling | 7.29e-04 | 55 | 66 | 3 | GO:0001881 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 7.36e-04 | 127 | 66 | 4 | GO:0070252 | |
| GeneOntologyBiologicalProcess | chloride transport | 7.57e-04 | 128 | 66 | 4 | GO:0006821 | |
| GeneOntologyBiologicalProcess | acetate ester transport | 7.69e-04 | 13 | 66 | 2 | GO:1901374 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | 7.72e-04 | 618 | 66 | 8 | GO:0090066 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 8.49e-04 | 230 | 66 | 5 | GO:0098739 | |
| GeneOntologyBiologicalProcess | intracellular pH reduction | 8.51e-04 | 58 | 66 | 3 | GO:0051452 | |
| GeneOntologyBiologicalProcess | response to nicotine | 8.51e-04 | 58 | 66 | 3 | GO:0035094 | |
| GeneOntologyBiologicalProcess | smooth muscle contraction | 8.74e-04 | 133 | 66 | 4 | GO:0006939 | |
| GeneOntologyBiologicalProcess | potassium ion transmembrane transport | 8.82e-04 | 232 | 66 | 5 | GO:0071805 | |
| GeneOntologyBiologicalProcess | regulation of adenylate cyclase activity | 8.95e-04 | 59 | 66 | 3 | GO:0045761 | |
| GeneOntologyBiologicalProcess | cellular response to brain-derived neurotrophic factor stimulus | 8.95e-04 | 14 | 66 | 2 | GO:1990416 | |
| GeneOntologyBiologicalProcess | lipid translocation | 9.40e-04 | 60 | 66 | 3 | GO:0034204 | |
| GeneOntologyBiologicalProcess | regulation of blood pressure | 9.70e-04 | 237 | 66 | 5 | GO:0008217 | |
| GeneOntologyBiologicalProcess | amine transport | 9.76e-04 | 137 | 66 | 4 | GO:0015837 | |
| GeneOntologyBiologicalProcess | regulation of secretion | CACNA1A CACNA1C CHRNA6 ADRA2C HTR2C KCNC3 AVPR1B ABCC8 CACNA1H | 9.78e-04 | 801 | 66 | 9 | GO:0051046 |
| GeneOntologyBiologicalProcess | organic hydroxy compound transport | 9.92e-04 | 358 | 66 | 6 | GO:0015850 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 1.03e-03 | 62 | 66 | 3 | GO:0086002 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | CACNA1A GPR89B CACNA1C HTR2C CLCN6 ABCC8 FSHR GPR89A GRIA1 RAB39A | 1.06e-03 | 981 | 66 | 10 | GO:0019725 |
| GeneOntologyBiologicalProcess | regulation of membrane lipid distribution | 1.19e-03 | 65 | 66 | 3 | GO:0097035 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | CACNA1A GPR89B CACNA1C CHRNA6 NALCN KCNC3 ABCC8 SCN3A SCN4A GPR89A GRIA1 GRIA2 GRIA3 GRIA4 CACNA1H KCNB2 TPCN1 | 1.85e-15 | 378 | 66 | 17 | GO:0034702 |
| GeneOntologyCellularComponent | transmembrane transporter complex | CACNA1A GPR89B CACNA1C CHRNA6 ZACN NALCN KCNC3 ABCC8 SCN3A SCN4A GPR89A GRIA1 GRIA2 GRIA3 GRIA4 CACNA1H KCNB2 TPCN1 | 2.49e-14 | 523 | 66 | 18 | GO:1902495 |
| GeneOntologyCellularComponent | transporter complex | CACNA1A GPR89B CACNA1C CHRNA6 ZACN NALCN KCNC3 ABCC8 SCN3A SCN4A GPR89A GRIA1 GRIA2 GRIA3 GRIA4 CACNA1H KCNB2 TPCN1 | 5.89e-14 | 550 | 66 | 18 | GO:1990351 |
| GeneOntologyCellularComponent | presynaptic membrane | CACNA1A CACNA1C CHRNA6 KCNC3 GRIA1 GRIA2 GRIA3 GRIA4 CACNA1H OPRD1 | 1.56e-08 | 277 | 66 | 10 | GO:0042734 |
| GeneOntologyCellularComponent | neuronal cell body | CACNA1A CACNA1C ADRA2C COPA KCNC3 SLC22A3 SCN3A NTSR2 MAST1 GRIA1 GRIA2 GRIA3 GRIA4 CACNA1H KCNB2 | 3.71e-08 | 835 | 66 | 15 | GO:0043025 |
| GeneOntologyCellularComponent | postsynaptic membrane | CACNA1A CACNA1C CHRNA6 ADRA2C KCNC3 GRIA1 GRIA2 GRIA3 GRIA4 CACNA1H OPRD1 | 5.21e-08 | 405 | 66 | 11 | GO:0045211 |
| GeneOntologyCellularComponent | cation channel complex | 5.22e-08 | 235 | 66 | 9 | GO:0034703 | |
| GeneOntologyCellularComponent | membrane protein complex | CACNA1A GPR89B CACNA1C CHRNA6 ZACN COPA NALCN KCNC3 ABCC8 SCN3A SCN4A GPR89A GRIA1 GRIA2 GRIA3 GRIA4 CACNA1H KCNB2 TPCN1 | 1.06e-07 | 1498 | 66 | 19 | GO:0098796 |
| GeneOntologyCellularComponent | cell body | CACNA1A CACNA1C ADRA2C COPA KCNC3 SLC22A3 SCN3A NTSR2 MAST1 GRIA1 GRIA2 GRIA3 GRIA4 CACNA1H KCNB2 | 1.49e-07 | 929 | 66 | 15 | GO:0044297 |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 1.69e-07 | 78 | 66 | 6 | GO:0048787 | |
| GeneOntologyCellularComponent | somatodendritic compartment | CACNA1A CACNA1C ADRA2C HTR2C COPA KCNC3 SLC22A3 SCN3A NTSR2 MAST1 GRIA1 GRIA2 GRIA3 GRIA4 CACNA1H KCNB2 OPRD1 | 1.71e-07 | 1228 | 66 | 17 | GO:0036477 |
| GeneOntologyCellularComponent | perikaryon | 4.99e-07 | 223 | 66 | 8 | GO:0043204 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 6.33e-07 | 157 | 66 | 7 | GO:0098839 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNA1A CACNA1C CHRNA6 KCNC3 ABCC8 SCN3A SCN4A GRIA1 GRIA2 GRIA3 GRIA4 CACNA1H KCNB2 | 8.68e-07 | 785 | 66 | 13 | GO:0098797 |
| GeneOntologyCellularComponent | synaptic membrane | CACNA1A CACNA1C CHRNA6 ADRA2C KCNC3 GRIA1 GRIA2 GRIA3 GRIA4 CACNA1H OPRD1 | 1.93e-06 | 583 | 66 | 11 | GO:0097060 |
| GeneOntologyCellularComponent | sodium channel complex | 2.03e-06 | 29 | 66 | 4 | GO:0034706 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | GPR89B CLCN6 COPA CAMKV AVPR2 ABCC8 GPR89A GRIA1 GRIA2 GRIA3 GRIA4 RAB39A RAB39B MCOLN3 OPRD1 TPCN1 | 2.17e-06 | 1307 | 66 | 16 | GO:0030659 |
| GeneOntologyCellularComponent | dendrite | CACNA1A CACNA1C HTR2C KCNC3 NTSR2 MAST1 GRIA1 GRIA2 GRIA3 GRIA4 CACNA1H KCNB2 OPRD1 | 2.33e-06 | 858 | 66 | 13 | GO:0030425 |
| GeneOntologyCellularComponent | AMPA glutamate receptor complex | 2.33e-06 | 30 | 66 | 4 | GO:0032281 | |
| GeneOntologyCellularComponent | dendritic tree | CACNA1A CACNA1C HTR2C KCNC3 NTSR2 MAST1 GRIA1 GRIA2 GRIA3 GRIA4 CACNA1H KCNB2 OPRD1 | 2.39e-06 | 860 | 66 | 13 | GO:0097447 |
| GeneOntologyCellularComponent | vesicle membrane | GPR89B CLCN6 COPA CAMKV AVPR2 ABCC8 GPR89A GRIA1 GRIA2 GRIA3 GRIA4 RAB39A RAB39B MCOLN3 OPRD1 TPCN1 | 2.59e-06 | 1325 | 66 | 16 | GO:0012506 |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 3.30e-06 | 201 | 66 | 7 | GO:0099634 | |
| GeneOntologyCellularComponent | presynapse | CACNA1A CACNA1C CHRNA6 ADRA2C KCNC3 ABCC8 SLC22A3 GRIA1 GRIA2 GRIA3 GRIA4 CACNA1H OPRD1 | 3.32e-06 | 886 | 66 | 13 | GO:0098793 |
| GeneOntologyCellularComponent | dendritic shaft | 3.66e-06 | 74 | 66 | 5 | GO:0043198 | |
| GeneOntologyCellularComponent | presynaptic active zone | 5.51e-06 | 141 | 66 | 6 | GO:0048786 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 1.22e-05 | 45 | 66 | 4 | GO:0008328 | |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 1.87e-05 | 50 | 66 | 4 | GO:0098878 | |
| GeneOntologyCellularComponent | axon | CACNA1C ADRA2C COPA KCNC3 SCN3A SCN4A MAST1 GRIA1 GRIA2 GRIA3 GRIA4 OPRD1 | 1.97e-05 | 891 | 66 | 12 | GO:0030424 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.98e-05 | 17 | 66 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | dendrite membrane | 2.94e-05 | 56 | 66 | 4 | GO:0032590 | |
| GeneOntologyCellularComponent | axon terminus | 5.26e-05 | 210 | 66 | 6 | GO:0043679 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 5.55e-05 | 212 | 66 | 6 | GO:0030666 | |
| GeneOntologyCellularComponent | perisynaptic space | 5.87e-05 | 4 | 66 | 2 | GO:0099544 | |
| GeneOntologyCellularComponent | cell projection membrane | 6.17e-05 | 431 | 66 | 8 | GO:0031253 | |
| GeneOntologyCellularComponent | postsynapse | CACNA1A CACNA1C CHRNA6 ADRA2C KCNC3 CAMKV GRIA1 GRIA2 GRIA3 GRIA4 CACNA1H OPRD1 | 7.19e-05 | 1018 | 66 | 12 | GO:0098794 |
| GeneOntologyCellularComponent | neuron projection terminus | 9.35e-05 | 233 | 66 | 6 | GO:0044306 | |
| GeneOntologyCellularComponent | dendritic spine | 1.15e-04 | 242 | 66 | 6 | GO:0043197 | |
| GeneOntologyCellularComponent | neuron spine | 1.29e-04 | 247 | 66 | 6 | GO:0044309 | |
| GeneOntologyCellularComponent | neuron projection membrane | 1.32e-04 | 82 | 66 | 4 | GO:0032589 | |
| GeneOntologyCellularComponent | glutamatergic synapse | CACNA1A CACNA1C ADRA2C KCNC3 CAMKV GRIA1 GRIA2 GRIA3 GRIA4 CACNA1H | 2.28e-04 | 817 | 66 | 10 | GO:0098978 |
| GeneOntologyCellularComponent | potassium channel complex | 3.29e-04 | 104 | 66 | 4 | GO:0034705 | |
| GeneOntologyCellularComponent | neuronal cell body membrane | 3.39e-04 | 43 | 66 | 3 | GO:0032809 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 4.14e-04 | 46 | 66 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | distal axon | 4.35e-04 | 435 | 66 | 7 | GO:0150034 | |
| GeneOntologyCellularComponent | cell body membrane | 4.41e-04 | 47 | 66 | 3 | GO:0044298 | |
| GeneOntologyCellularComponent | receptor complex | 4.72e-04 | 581 | 66 | 8 | GO:0043235 | |
| GeneOntologyCellularComponent | leading edge membrane | 5.30e-04 | 210 | 66 | 5 | GO:0031256 | |
| GeneOntologyCellularComponent | postsynaptic density | 5.40e-04 | 451 | 66 | 7 | GO:0014069 | |
| GeneOntologyCellularComponent | asymmetric synapse | 7.51e-04 | 477 | 66 | 7 | GO:0032279 | |
| GeneOntologyCellularComponent | Golgi-associated vesicle membrane | 9.49e-04 | 61 | 66 | 3 | GO:0030660 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 1.02e-03 | 503 | 66 | 7 | GO:0099572 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 1.28e-03 | 523 | 66 | 7 | GO:0098984 | |
| GeneOntologyCellularComponent | endocytic vesicle | 1.33e-03 | 384 | 66 | 6 | GO:0030139 | |
| GeneOntologyCellularComponent | dendritic spine membrane | 1.45e-03 | 18 | 66 | 2 | GO:0032591 | |
| GeneOntologyCellularComponent | calcium channel complex | 1.60e-03 | 73 | 66 | 3 | GO:0034704 | |
| GeneOntologyCellularComponent | brush border membrane | 2.31e-03 | 83 | 66 | 3 | GO:0031526 | |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 2.48e-03 | 179 | 66 | 4 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 2.48e-03 | 179 | 66 | 4 | GO:0030672 | |
| GeneOntologyCellularComponent | endosome | ADRA2C CLCN6 AVPR1B AVPR2 FSHR GRIA1 GCGR MCOLN3 SLC5A1 TPCN1 | 3.44e-03 | 1167 | 66 | 10 | GO:0005768 |
| GeneOntologyCellularComponent | terminal bouton | 3.48e-03 | 96 | 66 | 3 | GO:0043195 | |
| GeneOntologyCellularComponent | excitatory synapse | 4.72e-03 | 107 | 66 | 3 | GO:0060076 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 4.96e-03 | 350 | 66 | 5 | GO:0098802 | |
| GeneOntologyCellularComponent | Golgi-associated vesicle | 5.63e-03 | 114 | 66 | 3 | GO:0005798 | |
| GeneOntologyCellularComponent | endoplasmic reticulum-Golgi intermediate compartment | 1.01e-02 | 141 | 66 | 3 | GO:0005793 | |
| GeneOntologyCellularComponent | brush border | 1.23e-02 | 152 | 66 | 3 | GO:0005903 | |
| GeneOntologyCellularComponent | transport vesicle membrane | 1.38e-02 | 293 | 66 | 4 | GO:0030658 | |
| GeneOntologyCellularComponent | synaptic vesicle | 1.49e-02 | 300 | 66 | 4 | GO:0008021 | |
| MousePheno | abnormal pain threshold | 1.19e-06 | 267 | 57 | 9 | MP:0001970 | |
| MousePheno | hypoalgesia | 5.51e-06 | 170 | 57 | 7 | MP:0003043 | |
| MousePheno | abnormal touch/ nociception | 1.92e-05 | 376 | 57 | 9 | MP:0001968 | |
| MousePheno | abnormal seizure response to pharmacological agent | 2.85e-05 | 147 | 57 | 6 | MP:0000950 | |
| MousePheno | abnormal freezing behavior | 5.09e-05 | 163 | 57 | 6 | MP:0020420 | |
| MousePheno | abnormal response to novelty | CACNA1C HTR2C MGST2 CAMKV IL21R GRIA1 GRIA2 GRIA4 RAB39B KCNB2 XKR4 NEMP2 | 6.31e-05 | 787 | 57 | 12 | MP:0003107 |
| MousePheno | abnormal response to new environment | CACNA1C HTR2C MGST2 CAMKV IL21R GRIA1 GRIA2 GRIA4 KCNB2 XKR4 NEMP2 | 8.68e-05 | 687 | 57 | 11 | MP:0001413 |
| MousePheno | seizures | 9.83e-05 | 360 | 57 | 8 | MP:0002064 | |
| MousePheno | abnormal sleep pattern | 1.32e-04 | 64 | 57 | 4 | MP:0001501 | |
| MousePheno | abnormal AMPA-mediated synaptic currents | 1.56e-04 | 26 | 57 | 3 | MP:0002885 | |
| MousePheno | abnormal seizure response to inducing agent | 1.62e-04 | 201 | 57 | 6 | MP:0009357 | |
| MousePheno | jumpy | 1.62e-04 | 5 | 57 | 2 | MP:0001401 | |
| MousePheno | hypoactivity | CACNA1A CACNA1C HTR2C CLCN6 PIEZO1 SLC22A3 SCN3A GRIA1 GRIA2 GRIA4 GCGR KCNB2 XKR4 | 1.89e-04 | 1023 | 57 | 13 | MP:0031392 |
| MousePheno | decreased exploration in new environment | 2.01e-04 | 510 | 57 | 9 | MP:0001417 | |
| MousePheno | abnormal sleep behavior | 2.34e-04 | 137 | 57 | 5 | MP:0011396 | |
| MousePheno | abnormal behavioral response to xenobiotic | 2.47e-04 | 309 | 57 | 7 | MP:0009745 | |
| MousePheno | abnormal exploration in a new environment | CACNA1C MGST2 CAMKV IL21R GRIA1 GRIA2 GRIA4 KCNB2 XKR4 NEMP2 | 2.53e-04 | 647 | 57 | 10 | MP:0013189 |
| MousePheno | abnormal muscle electrophysiology | 2.93e-04 | 32 | 57 | 3 | MP:0004145 | |
| MousePheno | abnormal channel response | 3.22e-04 | 33 | 57 | 3 | MP:0003484 | |
| MousePheno | increased glycine level | 3.39e-04 | 7 | 57 | 2 | MP:0030658 | |
| MousePheno | mottled coat | 3.39e-04 | 7 | 57 | 2 | MP:0000421 | |
| MousePheno | variegated coat color | 4.50e-04 | 8 | 57 | 2 | MP:0005366 | |
| MousePheno | decreased chemical nociceptive threshold | 4.50e-04 | 8 | 57 | 2 | MP:0008532 | |
| MousePheno | abnormal thermal nociception | 5.97e-04 | 168 | 57 | 5 | MP:0002733 | |
| MousePheno | abnormal social investigation | 6.47e-04 | 171 | 57 | 5 | MP:0001360 | |
| MousePheno | abnormal sensory capabilities/reflexes/nociception | CACNA1A CACNA1C ADRA2C HTR2C CLCN6 SCN4A FSHR NTSR2 GRIA1 GRIA2 GRIA3 GRIA4 GCGR MCOLN3 OPRD1 | 6.85e-04 | 1486 | 57 | 15 | MP:0002067 |
| MousePheno | abnormal chemical nociception | 7.56e-04 | 44 | 57 | 3 | MP:0002735 | |
| Domain | Ion_trans_dom | CACNA1A CACNA1C NALCN KCNC3 SCN3A SCN4A CACNA1H KCNB2 MCOLN3 TPCN1 | 6.49e-12 | 114 | 65 | 10 | IPR005821 |
| Domain | Ion_trans | CACNA1A CACNA1C NALCN KCNC3 SCN3A SCN4A CACNA1H KCNB2 MCOLN3 TPCN1 | 6.49e-12 | 114 | 65 | 10 | PF00520 |
| Domain | Channel_four-helix_dom | 1.99e-11 | 57 | 65 | 8 | IPR027359 | |
| Domain | - | 1.99e-11 | 57 | 65 | 8 | 1.20.120.350 | |
| Domain | Iontro_rcpt | 3.94e-07 | 18 | 65 | 4 | IPR001320 | |
| Domain | Lig_chan | 3.94e-07 | 18 | 65 | 4 | PF00060 | |
| Domain | Lig_chan-Glu_bd | 3.94e-07 | 18 | 65 | 4 | PF10613 | |
| Domain | PBPe | 3.94e-07 | 18 | 65 | 4 | SM00079 | |
| Domain | Iono_rcpt_met | 3.94e-07 | 18 | 65 | 4 | IPR001508 | |
| Domain | Glu/Gly-bd | 3.94e-07 | 18 | 65 | 4 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 3.94e-07 | 18 | 65 | 4 | SM00918 | |
| Domain | VDCCAlpha1 | 4.74e-06 | 10 | 65 | 3 | IPR002077 | |
| Domain | XK_rel | 6.51e-06 | 11 | 65 | 3 | IPR018629 | |
| Domain | NA_SOLUT_SYMP_1 | 6.51e-06 | 11 | 65 | 3 | PS00456 | |
| Domain | XK-related | 6.51e-06 | 11 | 65 | 3 | PF09815 | |
| Domain | ANF_receptor | 8.09e-06 | 37 | 65 | 4 | PF01094 | |
| Domain | ANF_lig-bd_rcpt | 8.09e-06 | 37 | 65 | 4 | IPR001828 | |
| Domain | NA_SOLUT_SYMP_2 | 8.65e-06 | 12 | 65 | 3 | PS00457 | |
| Domain | SSF | 8.65e-06 | 12 | 65 | 3 | PF00474 | |
| Domain | Na/solute_symporter | 8.65e-06 | 12 | 65 | 3 | IPR001734 | |
| Domain | NA_SOLUT_SYMP_3 | 8.65e-06 | 12 | 65 | 3 | PS50283 | |
| Domain | Peripla_BP_I | 1.00e-05 | 39 | 65 | 4 | IPR028082 | |
| Domain | GPCR_Rhodpsn_7TM | OR5D16 ADRA2C HTR2C AVPR1B AVPR2 FSHR NTSR2 OR2W1 NMUR1 OPRD1 | 9.94e-05 | 670 | 65 | 10 | IPR017452 |
| Domain | 7tm_1 | OR5D16 ADRA2C HTR2C AVPR1B AVPR2 FSHR NTSR2 OR2W1 NMUR1 OPRD1 | 1.08e-04 | 677 | 65 | 10 | PF00001 |
| Domain | Vasoprsn_rcpt | 1.18e-04 | 5 | 65 | 2 | IPR001817 | |
| Domain | G_PROTEIN_RECEP_F1_1 | OR5D16 ADRA2C HTR2C AVPR1B AVPR2 FSHR NTSR2 OR2W1 NMUR1 OPRD1 | 1.19e-04 | 685 | 65 | 10 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR5D16 ADRA2C HTR2C AVPR1B AVPR2 FSHR NTSR2 OR2W1 NMUR1 OPRD1 | 1.28e-04 | 691 | 65 | 10 | PS50262 |
| Domain | GPCR_Rhodpsn | OR5D16 ADRA2C HTR2C AVPR1B AVPR2 FSHR NTSR2 OR2W1 NMUR1 OPRD1 | 1.30e-04 | 692 | 65 | 10 | IPR000276 |
| Domain | GPHH_dom | 2.48e-04 | 7 | 65 | 2 | IPR031649 | |
| Domain | VDCC_a1su_IQ | 2.48e-04 | 7 | 65 | 2 | IPR014873 | |
| Domain | Ca_chan_IQ | 2.48e-04 | 7 | 65 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 2.48e-04 | 7 | 65 | 2 | PF08763 | |
| Domain | GPHH | 2.48e-04 | 7 | 65 | 2 | PF16905 | |
| Domain | Na/solute_symporter_CS | 3.29e-04 | 8 | 65 | 2 | IPR018212 | |
| Domain | Na_channel_asu | 5.27e-04 | 10 | 65 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 5.27e-04 | 10 | 65 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 5.27e-04 | 10 | 65 | 2 | PF06512 | |
| Domain | 7TM_GPCR_Srsx | 6.26e-04 | 112 | 65 | 4 | SM01381 | |
| Domain | IQ | 2.83e-03 | 81 | 65 | 3 | SM00015 | |
| Domain | Acetylcholine_rcpt_TM | 2.88e-03 | 23 | 65 | 2 | IPR027361 | |
| Domain | - | 2.88e-03 | 23 | 65 | 2 | 1.20.120.370 | |
| Domain | IQ_motif_EF-hand-BS | 3.81e-03 | 90 | 65 | 3 | IPR000048 | |
| Domain | K_chnl_volt-dep_Kv | 3.96e-03 | 27 | 65 | 2 | IPR003968 | |
| Domain | VG_K_chnl | 5.87e-03 | 33 | 65 | 2 | IPR028325 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | CHRNA6 ADRA2C HTR2C AVPR1B AVPR2 FSHR NTSR2 GRIA1 GRIA2 GRIA3 NMUR1 GRIA4 GCGR OPRD1 | 6.52e-13 | 272 | 52 | 14 | M13380 |
| Pathway | WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA | 1.41e-08 | 22 | 52 | 5 | M39795 | |
| Pathway | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | 2.90e-07 | 16 | 52 | 4 | MM15048 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 3.62e-07 | 186 | 52 | 8 | MM15994 | |
| Pathway | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | 3.78e-07 | 17 | 52 | 4 | M5488 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 3.96e-07 | 260 | 52 | 9 | M39397 | |
| Pathway | WP_GPCRS_NONODORANT | 4.80e-07 | 266 | 52 | 9 | MM15843 | |
| Pathway | WP_NRXN1_DELETION_SYNDROME | 4.85e-07 | 18 | 52 | 4 | M48098 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 9.40e-07 | 21 | 52 | 4 | M838 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 1.15e-06 | 22 | 52 | 4 | MM15104 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 3.25e-06 | 335 | 52 | 9 | MM14503 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 3.65e-06 | 29 | 52 | 4 | MM15028 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 4.81e-06 | 31 | 52 | 4 | M7223 | |
| Pathway | WP_GPCRS_PEPTIDE | 5.66e-06 | 70 | 52 | 5 | MM15959 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 6.51e-06 | 72 | 52 | 5 | MM14631 | |
| Pathway | WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL | 6.97e-06 | 73 | 52 | 5 | MM16641 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 7.92e-06 | 35 | 52 | 4 | MM15109 | |
| Pathway | WP_PEPTIDE_GPCRS | 7.96e-06 | 75 | 52 | 5 | M39696 | |
| Pathway | WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION | 1.51e-05 | 41 | 52 | 4 | M39655 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | 1.69e-05 | 411 | 52 | 9 | M735 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 2.41e-05 | 430 | 52 | 9 | MM15160 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 2.54e-05 | 330 | 52 | 8 | M18334 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | 2.71e-05 | 333 | 52 | 8 | MM14963 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC6A18 CLCN6 NALCN AVPR2 SLC22A3 SLC5A8 SLC14A2 MCOLN3 SLC5A1 TPCN1 SLC5A4 | 3.04e-05 | 681 | 52 | 11 | MM14985 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | 4.31e-05 | 463 | 52 | 9 | M507 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 4.69e-05 | 108 | 52 | 5 | M17034 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 5.16e-05 | 20 | 52 | 3 | MM15485 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 6.01e-05 | 21 | 52 | 3 | M27736 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC6A18 CLCN6 NALCN AVPR2 SLC22A3 SLC5A8 SLC14A2 MCOLN3 SLC5A1 TPCN1 SLC5A4 | 6.17e-05 | 736 | 52 | 11 | M27287 |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 7.35e-05 | 61 | 52 | 4 | MM15071 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 7.96e-05 | 23 | 52 | 3 | M47666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 1.03e-04 | 25 | 52 | 3 | M47948 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 1.20e-04 | 211 | 52 | 6 | MM14502 | |
| Pathway | KEGG_LONG_TERM_DEPRESSION | 1.26e-04 | 70 | 52 | 4 | M8232 | |
| Pathway | WP_NRF2_PATHWAY | 1.66e-04 | 141 | 52 | 5 | M39454 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 1.83e-04 | 144 | 52 | 5 | MM14501 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 1.92e-04 | 78 | 52 | 4 | M1921 | |
| Pathway | REACTOME_VASOPRESSIN_LIKE_RECEPTORS | 1.98e-04 | 6 | 52 | 2 | M27289 | |
| Pathway | REACTOME_VASOPRESSIN_LIKE_RECEPTORS | 1.98e-04 | 6 | 52 | 2 | MM14989 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 2.18e-04 | 32 | 52 | 3 | M27455 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 2.31e-04 | 238 | 52 | 6 | MM15076 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 2.95e-04 | 249 | 52 | 6 | M5988 | |
| Pathway | WP_ADHD_AND_AUTISM_ASD_PATHWAYS | 3.73e-04 | 367 | 52 | 7 | M48346 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 3.93e-04 | 94 | 52 | 4 | M2843 | |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | 4.54e-04 | 270 | 52 | 6 | M15514 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | 4.75e-04 | 177 | 52 | 5 | M27476 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 4.78e-04 | 99 | 52 | 4 | MM14910 | |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 4.78e-04 | 99 | 52 | 4 | M27474 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 4.88e-04 | 178 | 52 | 5 | M2890 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 5.29e-04 | 646 | 52 | 9 | MM14962 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 6.20e-04 | 106 | 52 | 4 | M27200 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 6.85e-04 | 47 | 52 | 3 | M19708 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 7.19e-04 | 11 | 52 | 2 | M47958 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 7.73e-04 | 197 | 52 | 5 | M12289 | |
| Pathway | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | 7.73e-04 | 197 | 52 | 5 | MM14970 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 9.24e-04 | 205 | 52 | 5 | M752 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | 9.59e-04 | 702 | 52 | 9 | M746 | |
| Pathway | WP_NUCLEAR_RECEPTORS_METAPATHWAY | 1.00e-03 | 314 | 52 | 6 | M39428 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 1.03e-03 | 210 | 52 | 5 | MM15043 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 1.19e-03 | 217 | 52 | 5 | M18437 | |
| Pathway | WP_PROXIMAL_TUBULE_TRANSPORT | 1.20e-03 | 57 | 52 | 3 | M39812 | |
| Pathway | WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING | 1.74e-03 | 140 | 52 | 4 | M42572 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 1.92e-03 | 67 | 52 | 3 | MM15327 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 2.18e-03 | 70 | 52 | 3 | M3115 | |
| Pathway | REACTOME_CELLULAR_HEXOSE_TRANSPORT | 2.19e-03 | 19 | 52 | 2 | MM14718 | |
| Pathway | WP_GPCRS_ORPHAN | 2.19e-03 | 19 | 52 | 2 | MM15991 | |
| Pathway | WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME | 2.45e-03 | 73 | 52 | 3 | M39401 | |
| Pathway | REACTOME_CELLULAR_HEXOSE_TRANSPORT | 2.68e-03 | 21 | 52 | 2 | M27058 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 2.75e-03 | 76 | 52 | 3 | MM15072 | |
| Pathway | REACTOME_LONG_TERM_POTENTIATION | 3.21e-03 | 23 | 52 | 2 | M27949 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 3.65e-03 | 84 | 52 | 3 | M27334 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 3.99e-03 | 176 | 52 | 4 | MM15718 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 4.03e-03 | 87 | 52 | 3 | M27617 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 4.58e-03 | 183 | 52 | 4 | M997 | |
| Pathway | REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION | 4.74e-03 | 28 | 52 | 2 | M10679 | |
| Pathway | REACTOME_POTASSIUM_CHANNELS | 5.63e-03 | 98 | 52 | 3 | MM14545 | |
| Pathway | WP_MONOAMINE_GPCRS | 5.80e-03 | 31 | 52 | 2 | MM15871 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 5.80e-03 | 31 | 52 | 2 | M877 | |
| Pathway | REACTOME_POTASSIUM_CHANNELS | 6.46e-03 | 103 | 52 | 3 | M1073 | |
| Pathway | WP_MONOAMINE_GPCRS | 6.55e-03 | 33 | 52 | 2 | M39585 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 6.59e-03 | 203 | 52 | 4 | M5485 | |
| Pathway | REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING | 7.35e-03 | 35 | 52 | 2 | MM15144 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 6.11e-12 | 139 | 66 | 9 | 16985003 | |
| Pubmed | 1.18e-11 | 4 | 66 | 4 | 10688364 | ||
| Pubmed | AMPA receptor subunits expressed by single astrocytes in the juvenile mouse hippocampus. | 1.18e-11 | 4 | 66 | 4 | 9221927 | |
| Pubmed | Interaction proteomics reveals brain region-specific AMPA receptor complexes. | 1.18e-11 | 4 | 66 | 4 | 25337787 | |
| Pubmed | Auditory sensitivity regulation via rapid changes in expression of surface AMPA receptors. | 1.18e-11 | 4 | 66 | 4 | 17828255 | |
| Pubmed | 1.18e-11 | 4 | 66 | 4 | 24652293 | ||
| Pubmed | 1.18e-11 | 4 | 66 | 4 | 17409242 | ||
| Pubmed | 1.18e-11 | 4 | 66 | 4 | 14561864 | ||
| Pubmed | 1.18e-11 | 4 | 66 | 4 | 1319477 | ||
| Pubmed | AMPA receptors regulate dynamic equilibrium of presynaptic terminals in mature hippocampal networks. | 1.18e-11 | 4 | 66 | 4 | 12692557 | |
| Pubmed | 1.18e-11 | 4 | 66 | 4 | 12125045 | ||
| Pubmed | 1.18e-11 | 4 | 66 | 4 | 9648857 | ||
| Pubmed | 5.90e-11 | 5 | 66 | 4 | 16129400 | ||
| Pubmed | 5.90e-11 | 5 | 66 | 4 | 9482932 | ||
| Pubmed | 2.84e-10 | 45 | 66 | 6 | 25979088 | ||
| Pubmed | 4.12e-10 | 7 | 66 | 4 | 21368048 | ||
| Pubmed | Hippocampal AMPA receptor assemblies and mechanism of allosteric inhibition. | 4.12e-10 | 7 | 66 | 4 | 33981040 | |
| Pubmed | Impairment of AMPA receptor function in cerebellar granule cells of ataxic mutant mouse stargazer. | 4.12e-10 | 7 | 66 | 4 | 10407040 | |
| Pubmed | Glutamate receptors in cortical plasticity: molecular and cellular biology. | 4.12e-10 | 7 | 66 | 4 | 9016303 | |
| Pubmed | Glutamate receptors: brain function and signal transduction. | 4.12e-10 | 7 | 66 | 4 | 9651535 | |
| Pubmed | 4.12e-10 | 7 | 66 | 4 | 27076426 | ||
| Pubmed | Synaptic profiles during neurite extension, refinement and retraction in the developing cochlea. | 8.23e-10 | 8 | 66 | 4 | 23217150 | |
| Pubmed | 1.48e-09 | 9 | 66 | 4 | 24292102 | ||
| Pubmed | Expression of glutamate receptor subunit genes during development of the mouse retina. | 1.48e-09 | 9 | 66 | 4 | 9051806 | |
| Pubmed | 5.64e-09 | 300 | 66 | 9 | 19086053 | ||
| Pubmed | 5.79e-09 | 12 | 66 | 4 | 11891216 | ||
| Pubmed | 6.53e-09 | 3 | 66 | 3 | 36070750 | ||
| Pubmed | 6.53e-09 | 3 | 66 | 3 | 22094384 | ||
| Pubmed | 6.53e-09 | 3 | 66 | 3 | 32569783 | ||
| Pubmed | Long-term potentiation reconstituted with an artificial TARP/PSD-95 complex. | 6.53e-09 | 3 | 66 | 3 | 36223737 | |
| Pubmed | Persistent synaptic scaling independent of AMPA receptor subunit composition. | 6.53e-09 | 3 | 66 | 3 | 23864664 | |
| Pubmed | 6.53e-09 | 3 | 66 | 3 | 34426577 | ||
| Pubmed | 6.53e-09 | 3 | 66 | 3 | 22057216 | ||
| Pubmed | 6.53e-09 | 3 | 66 | 3 | 26216687 | ||
| Pubmed | 6.53e-09 | 3 | 66 | 3 | 15144856 | ||
| Pubmed | 6.53e-09 | 3 | 66 | 3 | 18163426 | ||
| Pubmed | 6.53e-09 | 3 | 66 | 3 | 12700243 | ||
| Pubmed | 6.53e-09 | 3 | 66 | 3 | 12172541 | ||
| Pubmed | 6.53e-09 | 3 | 66 | 3 | 15145077 | ||
| Pubmed | Synaptic transmission and plasticity require AMPA receptor anchoring via its N-terminal domain. | 6.53e-09 | 3 | 66 | 3 | 28290985 | |
| Pubmed | 6.53e-09 | 3 | 66 | 3 | 26585043 | ||
| Pubmed | Glutamatergic plasticity by synaptic delivery of GluR-B(long)-containing AMPA receptors. | 6.53e-09 | 3 | 66 | 3 | 14687553 | |
| Pubmed | Synaptic homeostasis requires the membrane-proximal carboxy tail of GluA2. | 6.53e-09 | 3 | 66 | 3 | 29180434 | |
| Pubmed | 6.53e-09 | 3 | 66 | 3 | 19217372 | ||
| Pubmed | Case-control association study of GRIA1, GRIA2 and GRIA4 polymorphisms in bipolar disorder. | 6.53e-09 | 3 | 66 | 3 | 22122651 | |
| Pubmed | Subunit composition of synaptic AMPA receptors revealed by a single-cell genetic approach. | 6.53e-09 | 3 | 66 | 3 | 19409270 | |
| Pubmed | 6.53e-09 | 3 | 66 | 3 | 21135237 | ||
| Pubmed | 6.53e-09 | 3 | 66 | 3 | 29581247 | ||
| Pubmed | Subunit-specific role for the amino-terminal domain of AMPA receptors in synaptic targeting. | 6.53e-09 | 3 | 66 | 3 | 28630296 | |
| Pubmed | LTP requires a reserve pool of glutamate receptors independent of subunit type. | 6.53e-09 | 3 | 66 | 3 | 23235828 | |
| Pubmed | 8.35e-09 | 13 | 66 | 4 | 25218043 | ||
| Pubmed | 1.07e-08 | 81 | 66 | 6 | 22723691 | ||
| Pubmed | 1.59e-08 | 15 | 66 | 4 | 9481670 | ||
| Pubmed | PICK1 interacts with ABP/GRIP to regulate AMPA receptor trafficking. | 2.12e-08 | 16 | 66 | 4 | 16055064 | |
| Pubmed | 2.61e-08 | 4 | 66 | 3 | 28608780 | ||
| Pubmed | 2.61e-08 | 4 | 66 | 3 | 26932439 | ||
| Pubmed | 2.61e-08 | 4 | 66 | 3 | 31231192 | ||
| Pubmed | 2.61e-08 | 4 | 66 | 3 | 31992779 | ||
| Pubmed | 2.61e-08 | 4 | 66 | 3 | 29915039 | ||
| Pubmed | Long-term potentiation is independent of the C-tail of the GluA1 AMPA receptor subunit. | 2.61e-08 | 4 | 66 | 3 | 32831170 | |
| Pubmed | Clustering of AMPA receptors by the synaptic PDZ domain-containing protein PICK1. | 2.61e-08 | 4 | 66 | 3 | 10027300 | |
| Pubmed | Cortactin regulates endo-lysosomal sorting of AMPARs via direct interaction with GluA2 subunit. | 2.61e-08 | 4 | 66 | 3 | 29515177 | |
| Pubmed | Functional importance of L- and P/Q-type voltage-gated calcium channels in human renal vasculature. | 2.61e-08 | 4 | 66 | 3 | 21788606 | |
| Pubmed | 2.61e-08 | 4 | 66 | 3 | 23664612 | ||
| Pubmed | 2.61e-08 | 4 | 66 | 3 | 30931998 | ||
| Pubmed | 2.61e-08 | 4 | 66 | 3 | 29581259 | ||
| Pubmed | AMPA receptor trafficking and synaptic plasticity require SQSTM1/p62. | 2.61e-08 | 4 | 66 | 3 | 19004011 | |
| Pubmed | 2.61e-08 | 4 | 66 | 3 | 12414093 | ||
| Pubmed | Motor protein-dependent transport of AMPA receptors into spines during long-term potentiation. | 3.55e-08 | 18 | 66 | 4 | 18311135 | |
| Pubmed | Phase Separation-Mediated TARP/MAGUK Complex Condensation and AMPA Receptor Synaptic Transmission. | 6.51e-08 | 5 | 66 | 3 | 31492534 | |
| Pubmed | RNF220 is an E3 ubiquitin ligase for AMPA receptors to regulate synaptic transmission. | 6.51e-08 | 5 | 66 | 3 | 36179027 | |
| Pubmed | RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. | 6.51e-08 | 5 | 66 | 3 | 1717158 | |
| Pubmed | 6.51e-08 | 5 | 66 | 3 | 15797551 | ||
| Pubmed | 1.02e-07 | 23 | 66 | 4 | 8464923 | ||
| Pubmed | Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. | 1.03e-07 | 118 | 66 | 6 | 19156168 | |
| Pubmed | 1.09e-07 | 200 | 66 | 7 | 18240029 | ||
| Pubmed | Glutamate can act as a signaling molecule in mouse preimplantation embryos†. | 1.22e-07 | 24 | 66 | 4 | 35746896 | |
| Pubmed | 1.22e-07 | 24 | 66 | 4 | 22632720 | ||
| Pubmed | 1.22e-07 | 24 | 66 | 4 | 22534482 | ||
| Pubmed | 1.30e-07 | 6 | 66 | 3 | 28194005 | ||
| Pubmed | 1.30e-07 | 6 | 66 | 3 | 30057205 | ||
| Pubmed | 1.30e-07 | 6 | 66 | 3 | 18922769 | ||
| Pubmed | 2.27e-07 | 7 | 66 | 3 | 15883194 | ||
| Pubmed | CKAMP44: a brain-specific protein attenuating short-term synaptic plasticity in the dentate gyrus. | 2.27e-07 | 7 | 66 | 3 | 20185686 | |
| Pubmed | 2.27e-07 | 7 | 66 | 3 | 17093100 | ||
| Pubmed | Stargazin regulates synaptic targeting of AMPA receptors by two distinct mechanisms. | 2.27e-07 | 7 | 66 | 3 | 11140673 | |
| Pubmed | 2.27e-07 | 7 | 66 | 3 | 1310861 | ||
| Pubmed | Hippocampal AMPA receptor gating controlled by both TARP and cornichon proteins. | 3.63e-07 | 8 | 66 | 3 | 21172611 | |
| Pubmed | 5.44e-07 | 9 | 66 | 3 | 16382099 | ||
| Pubmed | Ion channel expression in the developing enteric nervous system. | 7.45e-07 | 37 | 66 | 4 | 25798587 | |
| Pubmed | Exposure of phosphatidylserine by Xk-related protein family members during apoptosis. | 7.76e-07 | 10 | 66 | 3 | 25231987 | |
| Pubmed | Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol. | 1.84e-06 | 13 | 66 | 3 | 20859245 | |
| Pubmed | From the Cover: Indispensability of the glutamate transporters GLAST and GLT1 to brain development. | 2.34e-06 | 14 | 66 | 3 | 16880397 | |
| Pubmed | Amyloid-β effects on synapses and memory require AMPA receptor subunit GluA3. | 3.55e-06 | 2 | 66 | 2 | 27708157 | |
| Pubmed | Synaptic plasticity through activation of GluA3-containing AMPA-receptors. | 3.55e-06 | 2 | 66 | 2 | 28762944 | |
| Pubmed | L-type calcium channels contribute to the tottering mouse dystonic episodes. | 3.55e-06 | 2 | 66 | 2 | 9882694 | |
| Pubmed | Kinetic properties of human AMPA-type glutamate receptors expressed in HEK293 cells. | 3.55e-06 | 2 | 66 | 2 | 12670305 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 22770842 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 30146304 | ||
| Pubmed | Deregulation of the A-to-I RNA editing mechanism in psychiatric disorders. | 3.55e-06 | 2 | 66 | 2 | 21984433 | |
| Interaction | GPR89A interactions | 1.04e-07 | 120 | 64 | 7 | int:GPR89A | |
| Interaction | YIPF3 interactions | 1.29e-07 | 186 | 64 | 8 | int:YIPF3 | |
| Interaction | TSPAN15 interactions | 2.12e-07 | 276 | 64 | 9 | int:TSPAN15 | |
| Interaction | CACNA1D interactions | 9.37e-07 | 24 | 64 | 4 | int:CACNA1D | |
| Interaction | GCGR interactions | 1.34e-06 | 110 | 64 | 6 | int:GCGR | |
| Interaction | GRIA4 interactions | 8.57e-06 | 41 | 64 | 4 | int:GRIA4 | |
| Interaction | GRIA3 interactions | 1.04e-05 | 43 | 64 | 4 | int:GRIA3 | |
| Interaction | DPY19L4 interactions | 1.04e-05 | 43 | 64 | 4 | int:DPY19L4 | |
| Interaction | SCN11A interactions | 1.35e-05 | 15 | 64 | 3 | int:SCN11A | |
| Interaction | POMK interactions | 2.38e-05 | 271 | 64 | 7 | int:POMK | |
| Interaction | SCN9A interactions | 3.90e-05 | 21 | 64 | 3 | int:SCN9A | |
| Interaction | TMEM219 interactions | 5.17e-05 | 23 | 64 | 3 | int:TMEM219 | |
| Interaction | SLC19A2 interactions | 6.85e-05 | 69 | 64 | 4 | int:SLC19A2 | |
| Interaction | TRO interactions | 6.85e-05 | 69 | 64 | 4 | int:TRO | |
| Interaction | PIGN interactions | 7.66e-05 | 71 | 64 | 4 | int:PIGN | |
| Interaction | ERMP1 interactions | 1.04e-04 | 147 | 64 | 5 | int:ERMP1 | |
| Interaction | SCN1A interactions | 1.05e-04 | 29 | 64 | 3 | int:SCN1A | |
| Interaction | TSPAN7 interactions | 1.42e-04 | 32 | 64 | 3 | int:TSPAN7 | |
| Interaction | SHISA9 interactions | 1.48e-04 | 6 | 64 | 2 | int:SHISA9 | |
| Interaction | CACNG2 interactions | 1.56e-04 | 33 | 64 | 3 | int:CACNG2 | |
| Interaction | GRIA1 interactions | 1.62e-04 | 86 | 64 | 4 | int:GRIA1 | |
| Interaction | SGCB interactions | 1.69e-04 | 87 | 64 | 4 | int:SGCB | |
| Interaction | FADS1 interactions | 1.69e-04 | 87 | 64 | 4 | int:FADS1 | |
| Interaction | ARLN interactions | 2.01e-04 | 91 | 64 | 4 | int:ARLN | |
| Interaction | CACNA1B interactions | 2.20e-04 | 37 | 64 | 3 | int:CACNA1B | |
| Interaction | GRIP1 interactions | 2.47e-04 | 96 | 64 | 4 | int:GRIP1 | |
| Interaction | CPT1C interactions | 2.75e-04 | 8 | 64 | 2 | int:CPT1C | |
| Interaction | VAPA interactions | 3.01e-04 | 686 | 64 | 9 | int:VAPA | |
| Interaction | RNF220 interactions | 3.21e-04 | 42 | 64 | 3 | int:RNF220 | |
| Interaction | MT-ATP8 interactions | 3.44e-04 | 43 | 64 | 3 | int:MT-ATP8 | |
| Interaction | SLC22A4 interactions | 3.60e-04 | 192 | 64 | 5 | int:SLC22A4 | |
| Interaction | KCNJ8 interactions | 3.69e-04 | 44 | 64 | 3 | int:KCNJ8 | |
| Interaction | SGPP1 interactions | 4.21e-04 | 46 | 64 | 3 | int:SGPP1 | |
| Interaction | SCN5A interactions | 4.48e-04 | 47 | 64 | 3 | int:SCN5A | |
| Interaction | GRIA2 interactions | 4.65e-04 | 203 | 64 | 5 | int:GRIA2 | |
| Interaction | NIPAL1 interactions | 4.75e-04 | 114 | 64 | 4 | int:NIPAL1 | |
| Interaction | GJA1 interactions | 4.97e-04 | 583 | 64 | 8 | int:GJA1 | |
| Interaction | ALG10 interactions | 5.07e-04 | 49 | 64 | 3 | int:ALG10 | |
| Interaction | SLC22A9 interactions | 5.77e-04 | 120 | 64 | 4 | int:SLC22A9 | |
| Interaction | CACNA1A interactions | 6.33e-04 | 123 | 64 | 4 | int:CACNA1A | |
| Interaction | TMEM207 interactions | 6.42e-04 | 12 | 64 | 2 | int:TMEM207 | |
| Interaction | OLFM1 interactions | 7.51e-04 | 56 | 64 | 3 | int:OLFM1 | |
| Interaction | ATP2A3 interactions | 8.50e-04 | 232 | 64 | 5 | int:ATP2A3 | |
| Interaction | MFSD8 interactions | 8.75e-04 | 59 | 64 | 3 | int:MFSD8 | |
| Interaction | GRIP2 interactions | 8.81e-04 | 14 | 64 | 2 | int:GRIP2 | |
| Interaction | NALCN interactions | 8.81e-04 | 14 | 64 | 2 | int:NALCN | |
| Interaction | CACNG3 interactions | 8.81e-04 | 14 | 64 | 2 | int:CACNG3 | |
| Interaction | GRPR interactions | 9.64e-04 | 61 | 64 | 3 | int:GRPR | |
| Interaction | CACNA1C interactions | 9.64e-04 | 61 | 64 | 3 | int:CACNA1C | |
| Interaction | CMTM5 interactions | 9.71e-04 | 239 | 64 | 5 | int:CMTM5 | |
| Interaction | FPR2 interactions | 9.73e-04 | 138 | 64 | 4 | int:FPR2 | |
| Interaction | SNX14 interactions | 1.01e-03 | 62 | 64 | 3 | int:SNX14 | |
| Interaction | SLC5A3 interactions | 1.01e-03 | 62 | 64 | 3 | int:SLC5A3 | |
| Interaction | CABP1 interactions | 1.02e-03 | 15 | 64 | 2 | int:CABP1 | |
| Interaction | ELFN1 interactions | 1.02e-03 | 15 | 64 | 2 | int:ELFN1 | |
| Interaction | GP1BB interactions | 1.06e-03 | 63 | 64 | 3 | int:GP1BB | |
| Interaction | SERINC1 interactions | 1.06e-03 | 63 | 64 | 3 | int:SERINC1 | |
| GeneFamily | Glutamate ionotropic receptor AMPA type subunits | 6.58e-11 | 4 | 53 | 4 | 1200 | |
| GeneFamily | Blood group antigens|XK related family | 3.86e-06 | 11 | 53 | 3 | 955 | |
| GeneFamily | Solute carriers | SLC6A18 SLC22A3 SLC19A2 SLC35E3 SLC5A8 SLC14A2 SLC5A1 SLC5A4 | 1.81e-05 | 395 | 53 | 8 | 752 |
| GeneFamily | Arginine vasopressin and oxytocin receptors | 5.04e-05 | 4 | 53 | 2 | 259 | |
| GeneFamily | Calcium voltage-gated channel subunits | 5.90e-05 | 26 | 53 | 3 | 253 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 3.00e-04 | 9 | 53 | 2 | 1203 | |
| GeneFamily | Potassium voltage-gated channels | 6.12e-03 | 40 | 53 | 2 | 274 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 6.73e-03 | 42 | 53 | 2 | 602 | |
| GeneFamily | X-linked mental retardation|Angiotensin receptors | 1.06e-02 | 53 | 53 | 2 | 103 | |
| GeneFamily | RAB, member RAS oncogene GTPases | 1.56e-02 | 65 | 53 | 2 | 388 | |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_UP | CACNA1A CACNA1C CHRNA6 HTR2C NALCN KCNC3 CAMKV AVPR1B AVPR2 ABCC8 SCN3A GRIA1 GRIA3 CACNA1H GCGR OPRD1 SLC5A1 | 9.37e-09 | 1281 | 65 | 17 | M1884 |
| Coexpression | PGF_UP.V1_DN | 4.60e-07 | 190 | 65 | 7 | M2673 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA2 | CACNA1A CHRNA6 NALCN ABCC8 SCN3A MAST1 GRIA2 GRIA3 XKR6 XKR4 | 5.16e-07 | 513 | 65 | 10 | M39069 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HSERT | 1.63e-06 | 450 | 65 | 9 | M39072 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | 2.14e-06 | 465 | 65 | 9 | M39066 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | CACNA1A CACNA1C NALCN SCN3A MAST1 GRIA1 GRIA2 GRIA4 XKR6 XKR4 | 8.55e-06 | 703 | 65 | 10 | M39070 |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | 1.47e-05 | 591 | 65 | 9 | M2019 | |
| Coexpression | MIKKELSEN_MEF_HCP_WITH_H3K27ME3 | 1.68e-05 | 601 | 65 | 9 | MM866 | |
| Coexpression | MURARO_PANCREAS_PANCREATIC_POLYPEPTIDE_CELL | 3.95e-05 | 153 | 65 | 5 | M39171 | |
| Coexpression | NOURUZI_NEPC_ASCL1_TARGETS | 4.75e-05 | 159 | 65 | 5 | M46420 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_INTERM_NEUROENDOCRINE_CELL | 5.38e-05 | 268 | 65 | 6 | M45696 | |
| Coexpression | VALK_AML_CLUSTER_13 | 6.23e-05 | 31 | 65 | 3 | M2603 | |
| Coexpression | DESCARTES_FETAL_LUNG_NEUROENDOCRINE_CELLS | 7.83e-05 | 91 | 65 | 4 | M40240 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CACNA1A CACNA1C THSD7A NALCN SCN3A MAST1 GRIA1 GRIA2 GRIA4 XKR6 XKR4 | 7.94e-05 | 1106 | 65 | 11 | M39071 |
| Coexpression | GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_UP | 1.34e-04 | 198 | 65 | 5 | M4727 | |
| Coexpression | GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_UP | 1.40e-04 | 200 | 65 | 5 | M5089 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3 | 2.31e-04 | 350 | 65 | 6 | M1949 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3 | 2.57e-04 | 357 | 65 | 6 | MM828 | |
| CoexpressionAtlas | cerebral cortex | CACNA1A XKR7 HTR2C NALCN CAMKV ABCC8 SCN3A NTSR2 MAST1 GRIA1 GRIA2 GRIA3 GRIA4 RAB39A RAB39B KCNB2 XKR4 OPRD1 | 1.31e-07 | 1428 | 64 | 18 | cerebral cortex |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.93e-10 | 173 | 66 | 8 | 07798461d12d04f3dabff03481c999cb07c5af2f | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.06e-10 | 190 | 66 | 8 | 2375e604eacd38f61f3e661ba2f76d286fcceca7 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.06e-10 | 190 | 66 | 8 | b1095b2a7467c152d16e4f19a9515aeb61fc9e3d | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.60e-10 | 193 | 66 | 8 | 8603d1a38955ad2529d04e4704467c73ea5bfbda | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.63e-10 | 198 | 66 | 8 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-neuro-epithelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.97e-09 | 176 | 66 | 7 | fb718a6b07aa5d56600263280afa530bcb63db42 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.21e-08 | 187 | 66 | 7 | 98477ba04a42a8da80a72f41a182429f46283595 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.45e-08 | 192 | 66 | 7 | fe9297cb65234d9f511bab1a5dbf2679d5a4cd15 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.62e-08 | 195 | 66 | 7 | 5f33ece997f074598b4201ff74f592ee07c86a06 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.68e-08 | 196 | 66 | 7 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.80e-08 | 198 | 66 | 7 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.51e-07 | 162 | 66 | 6 | 478cf560ef33c5c324142c76417447d4a571a2c9 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-neuro-epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.22e-07 | 173 | 66 | 6 | 30fa8c14c8a1f546f380132c0c28a61e6a2f9fc4 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.30e-07 | 174 | 66 | 6 | 9f114e61458659005b6d0b4aa30a7a059e7aa5c6 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.30e-07 | 174 | 66 | 6 | a62531ebf16b32b249168dca11b870f63a8aa81c | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.38e-07 | 175 | 66 | 6 | 182e45f5c02214d6b9f317ff5dc43af8b42de978 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-neuro-epithelial-N_cells_(NTS+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.38e-07 | 175 | 66 | 6 | 97a58bc6ed2e8e359283d4214172c990c6e3755e | |
| ToppCell | COPD-Epithelial-PNEC|Epithelial / Disease state, Lineage and Cell class | 2.72e-07 | 179 | 66 | 6 | 988d0853c391da1e5004f73f3678047418d3f6d3 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 3.00e-07 | 182 | 66 | 6 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-07 | 184 | 66 | 6 | 3da93e7d8b62463e307cc0425c47dbd3bef66799 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-07 | 184 | 66 | 6 | 3e5c68a99c10eb1ddc1048bea4aa9f6b8e2746ff | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-07 | 184 | 66 | 6 | 1e2f0cec50475a1cf2973a5082826bbc60fc9a68 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-07 | 186 | 66 | 6 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.63e-07 | 188 | 66 | 6 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | 18-Airway-Epithelial-Neuroendocrine|Airway / Age, Tissue, Lineage and Cell class | 3.74e-07 | 189 | 66 | 6 | 144beb01b908f2cd0e04513fb84d817e0c3c124e | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.86e-07 | 190 | 66 | 6 | 5f1863bce9400b7c932f0e4d0e012ec4e8d7e555 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_neuroendocrine2[NE2]_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.98e-07 | 191 | 66 | 6 | 19832ddd559a353e1618fe853d79e3edfec6dcda | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-07 | 191 | 66 | 6 | 60bc1f3efa7bbad5cb7944fe5e049ea79cd1745a | |
| ToppCell | 11.5-Distal-Epithelial-Neuroendocrine|Distal / Age, Tissue, Lineage and Cell class | 4.49e-07 | 195 | 66 | 6 | eda6ebe52c48bd6a9044886e75f584f46c2556e7 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.91e-07 | 198 | 66 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.91e-07 | 198 | 66 | 6 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 5.21e-07 | 200 | 66 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Cortical_neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 5.21e-07 | 200 | 66 | 6 | 68c90376e2779434e4ad8dc6dd3b44baa700e2f4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.43e-06 | 155 | 66 | 5 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 4.01e-06 | 160 | 66 | 5 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.52e-06 | 164 | 66 | 5 | be49af6335f2505065cde2cb9800e4a5516811b1 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.80e-06 | 166 | 66 | 5 | d96c562e1483adb4cdd817b68133f03356d7279b | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.80e-06 | 166 | 66 | 5 | afba41e15478053f11815acf568d29187de75492 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.94e-06 | 167 | 66 | 5 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.39e-06 | 170 | 66 | 5 | 6a98f47f8c2b5b15e09169bd82eff1e6bf76e5a6 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.54e-06 | 171 | 66 | 5 | b7cddb8f726a43fb8a37f3e67a3f722e2178fd7a | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial-N_cells_(NTS+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.86e-06 | 173 | 66 | 5 | f31e738c2b3b319fb40b0b16b2393a51c9a8999c | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.03e-06 | 174 | 66 | 5 | 3503c7dec498597f76a86dbd5e4bb2311e743bde | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_neuroendocrine1[NE1]_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.20e-06 | 175 | 66 | 5 | 9941c35601134d88d1b3249c81f8b43a8fc61610 | |
| ToppCell | COVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.20e-06 | 175 | 66 | 5 | 1125f0d3a5b2388fa77a820dea0288e824d84a82 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 6.20e-06 | 175 | 66 | 5 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.20e-06 | 175 | 66 | 5 | 5a9160a9d05e01d945e77fd81bb0bd87139545cd | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 6.20e-06 | 175 | 66 | 5 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.37e-06 | 176 | 66 | 5 | 116741fef5895ca85057d2d31eca9eba5764ab44 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.37e-06 | 176 | 66 | 5 | 2e1003dc373b14d27f0464d980453fdcfc1005f0 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.37e-06 | 176 | 66 | 5 | 5b707f58d164ee7a6a527dd5d053472ce9a631c1 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.73e-06 | 178 | 66 | 5 | 20d9433332b58270bca6807a6cf633971dbaa2b7 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-neuro-epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.92e-06 | 179 | 66 | 5 | f93e81a3fd94adedb24a9db4ac1d53e275bbf8b5 | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 6.92e-06 | 179 | 66 | 5 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 7.30e-06 | 181 | 66 | 5 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.50e-06 | 182 | 66 | 5 | 420a8fd30543e37a66ba0786215d056d308660d0 | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.50e-06 | 182 | 66 | 5 | 398ce074a04f6482470b488f1affae4af7d2ec58 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.50e-06 | 182 | 66 | 5 | 1923932a9c60e9ec33db69ded441210d1fb07bec | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.50e-06 | 182 | 66 | 5 | 69ff652f74cc47fbe0bd665ab17c445c5b959dad | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.12e-06 | 185 | 66 | 5 | 2a8104f610fa5ce618f8105521616722462a0d42 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_neuroendocrine2[NE2]_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.34e-06 | 186 | 66 | 5 | c7983281a290201567b398e9ea6baddb96c692bb | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.34e-06 | 186 | 66 | 5 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | wk_20-22-Endothelial-Lymph_endothelial-SCG3+_lymphatic_endothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.55e-06 | 187 | 66 | 5 | 55aad84b992412e487a32f4970620189a7380ba6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.78e-06 | 188 | 66 | 5 | 1f912ea015f50570e848259d948a0ba682d64bb4 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.78e-06 | 188 | 66 | 5 | e99e3765b48392c987cf0c5ccbded0655637d7b7 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.78e-06 | 188 | 66 | 5 | e239bcdbd210a398a5850cb6fbf171d402f45a4f | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.78e-06 | 188 | 66 | 5 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.24e-06 | 190 | 66 | 5 | 40d8b3403f4e38436b961cd3a2e69826cbae3042 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine-Neuroendocrine_L.0.7.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.24e-06 | 190 | 66 | 5 | f6cbf6d292f488ada5f7581e1dceba6198b933d1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.24e-06 | 190 | 66 | 5 | a9a705455019e28d655636de73b07540798f82e6 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.24e-06 | 190 | 66 | 5 | b5c6f3248c0c2f648e1578457c6a729ca22bf0da | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.48e-06 | 191 | 66 | 5 | 8e8beb8e8a3b33cac83d3f7ce915a71e3654fdab | |
| ToppCell | 15-Trachea-Epithelial-Neuroendocrine|Trachea / Age, Tissue, Lineage and Cell class | 9.48e-06 | 191 | 66 | 5 | 76311fa5f3ae9bb27cf04387a8c92300f2888c28 | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial-Intermediate_lymphatic_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.48e-06 | 191 | 66 | 5 | d25ac3206fe205a100cfee26431ff32c14c1938f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.72e-06 | 192 | 66 | 5 | 3abee376c37c3646da33ac381aa63d50a01607a6 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo-epi_neuroendocrine2[NE2]_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.72e-06 | 192 | 66 | 5 | 4d3a1c267739b1479217144656986972fc86db43 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.97e-06 | 193 | 66 | 5 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.97e-06 | 193 | 66 | 5 | a189d46c39067b717509cd144e0225cc93d7731d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.97e-06 | 193 | 66 | 5 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.97e-06 | 193 | 66 | 5 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-05 | 194 | 66 | 5 | 4d6c9b016e3a0641954a8ea10c97d1cd76fadd9f | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-05 | 196 | 66 | 5 | 4bdc304c0c9d8bebe1a6a8a27e44acd1e8113725 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-05 | 197 | 66 | 5 | fd43fc1cbf0c17b370397d73dddc572565a759c7 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.13e-05 | 198 | 66 | 5 | 8f25e8dff42bad8e779ca618bdb1cb1610667962 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.13e-05 | 198 | 66 | 5 | e3e0aa3ef20b2370f5b133048510677aaa562dfa | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-cortical_neurons_1|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.13e-05 | 198 | 66 | 5 | d81f35c0066558ff96dd06f58fca72cd82e681e8 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.18e-05 | 200 | 66 | 5 | 04699d1149a143b96d6f292c0d70c4d3e6dfc611 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.18e-05 | 200 | 66 | 5 | 979258173b82f37aeaaedd53b4a527da1dbe1b80 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-8|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.86e-05 | 118 | 66 | 4 | e3dca31f47324ee207b773145475147fe3e761fe | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.15e-05 | 121 | 66 | 4 | 05c40fd39e6b6275f35aaad835f95a81fcbb0990 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-05 | 138 | 66 | 4 | e2659949944bdf39b23c7275e380a7a937e2726c | |
| ToppCell | RA-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 5.27e-05 | 138 | 66 | 4 | 5a713f24f633de463ef47ca37fbb2bb60c7fdb77 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-05 | 138 | 66 | 4 | d5342383c5e52b92c39d7afe76560501be3ea5cd | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Sc17a7.Tshz2-Smoc1_(Agranular_Retrosplenial_cortex_(RSG)_(Smoc1+))-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.29e-05 | 49 | 66 | 3 | 4845246699a56fea657fd2697b612e93248f590f | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Sc17a7.Tshz2-Smoc1_(Agranular_Retrosplenial_cortex_(RSG)_(Smoc1+))|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.29e-05 | 49 | 66 | 3 | 5f1c5ebb6f113513b7e6945dfab07c3c34ebab41 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-5|TCGA-Stomach / Sample_Type by Project: Shred V9 | 5.42e-05 | 139 | 66 | 4 | 849e4c060c9cf9eb7962caf5b169e72da4d85e70 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1|Striatum / BrainAtlas - Mouse McCarroll V32 | 6.56e-05 | 146 | 66 | 4 | 7b863f9bc63dc1afe015a18a70cd6ed0b71d1f09 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.74e-05 | 147 | 66 | 4 | 8f725ff8fb4ced5db2643e80669d3f7945b820ab | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(NPW+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.27e-05 | 155 | 66 | 4 | 498e52e2364ff44d3c0c707ba22468217031f5bd | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.13e-05 | 159 | 66 | 4 | 7747cef94c55144fddcd024a7495318357f1351b | |
| Computational | Ion channels. | 3.27e-06 | 70 | 36 | 5 | MODULE_316 | |
| Drug | sodium | SLC6A18 GPR89B CACNA1C CHRNA6 ZACN SLC22A3 SCN3A SCN4A SLC19A2 GRIA1 GRIA2 GRIA3 GRIA4 CACNA1H SLC5A8 SLC14A2 MCOLN3 OPRD1 SLC5A1 TPCN1 SLC5A4 | 8.06e-14 | 944 | 65 | 21 | CID000000923 |
| Drug | lamotrigine | 4.25e-11 | 116 | 65 | 9 | CID000003878 | |
| Drug | 3-pyridazinol 1-oxide | 6.05e-11 | 4 | 65 | 4 | CID000574311 | |
| Drug | tetradotoxin | CACNA1A CACNA1C CHRNA6 HTR2C SCN3A SCN4A NTSR2 GRIA1 GRIA2 GRIA3 GRIA4 CACNA1H OPRD1 | 2.07e-10 | 428 | 65 | 13 | CID000020382 |
| Drug | AC1L1YEG | 3.02e-10 | 5 | 65 | 4 | CID000063114 | |
| Drug | Chicago acid | 3.02e-10 | 5 | 65 | 4 | CID000065740 | |
| Drug | CHEBI:570577 | 3.02e-10 | 5 | 65 | 4 | CID011334126 | |
| Drug | 1-BCP | 3.02e-10 | 5 | 65 | 4 | CID000001370 | |
| Drug | irampanel | 3.02e-10 | 5 | 65 | 4 | CID003038472 | |
| Drug | beta-N-oxalylaminoalanine | 3.02e-10 | 5 | 65 | 4 | CID000107978 | |
| Drug | LY395153 | 3.02e-10 | 5 | 65 | 4 | CID000656707 | |
| Drug | 5-h PCA | 3.02e-10 | 5 | 65 | 4 | CID000129091 | |
| Drug | decahydroisoquinoline | 6.91e-10 | 16 | 65 | 5 | CID000097812 | |
| Drug | 2cmo | 9.03e-10 | 6 | 65 | 4 | CID006914597 | |
| Drug | YM928 | 9.03e-10 | 6 | 65 | 4 | CID006918393 | |
| Drug | gabapentin | 1.24e-09 | 169 | 65 | 9 | CID000003446 | |
| Drug | riluzole | 1.60e-09 | 174 | 65 | 9 | CID000005070 | |
| Drug | SKF 81297 | 2.07e-09 | 42 | 65 | 6 | CID000001218 | |
| Drug | thio-ATPA | 2.10e-09 | 7 | 65 | 4 | CID005289517 | |
| Drug | 4,6-dichloroindole-2-carboxylic acid | 2.10e-09 | 7 | 65 | 4 | CID000127988 | |
| Drug | strychnine HCl | 2.26e-09 | 181 | 65 | 9 | CID000005304 | |
| Drug | CNQX | 2.72e-09 | 126 | 65 | 8 | CID000002821 | |
| Drug | 4-AP | CACNA1A GPR89B CACNA1C KCNC3 SCN4A GRIA1 GRIA2 GRIA3 GRIA4 KCNB2 | 3.04e-09 | 258 | 65 | 10 | CID000001727 |
| Drug | N-methyl-DL-aspartic acid | CACNA1A CACNA1C CHRNA6 ZACN HTR2C CAMKV SCN4A GRIA1 GRIA2 GRIA3 GRIA4 CACNA1H OPRD1 TPCN1 | 3.65e-09 | 655 | 65 | 14 | CID000004376 |
| Drug | NS 102 | 4.11e-09 | 22 | 65 | 5 | CID005282252 | |
| Drug | 2,3-PDCA | 4.20e-09 | 8 | 65 | 4 | CID000127037 | |
| Drug | homoibotenic acid | 4.20e-09 | 8 | 65 | 4 | CID000194385 | |
| Drug | 1-hydroxypyrazole | 4.20e-09 | 8 | 65 | 4 | CID003016733 | |
| Drug | 1-hydroxyimidazole | 4.20e-09 | 8 | 65 | 4 | CID003614351 | |
| Drug | isoflurane | CACNA1C CHRNA6 ZACN COPA SCN3A SCN4A GRIA1 GRIA2 GRIA3 GRIA4 | 6.43e-09 | 279 | 65 | 10 | CID000003763 |
| Drug | hexachlorophene | 6.87e-09 | 90 | 65 | 7 | CID000003598 | |
| Drug | Ly294486 | 7.54e-09 | 9 | 65 | 4 | CID005311255 | |
| Drug | 1m5b | 7.54e-09 | 9 | 65 | 4 | CID000447081 | |
| Drug | isothiazol-3-one | 7.54e-09 | 9 | 65 | 4 | CID000096917 | |
| Drug | gamma-aminobutyric acid | CACNA1A CACNA1C CHRNA6 ZACN HTR2C CLCN6 GRIA1 GRIA2 GRIA3 GRIA4 CACNA1H OPRD1 | 8.56e-09 | 474 | 65 | 12 | CID000000119 |
| Drug | MK-801 | CACNA1C CHRNA6 ZACN HTR2C NTSR2 GRIA1 GRIA2 GRIA3 GRIA4 OPRD1 | 1.13e-08 | 296 | 65 | 10 | CID000001207 |
| Drug | Benzoates | 1.25e-08 | 10 | 65 | 4 | ctd:D001565 | |
| Drug | pentobarbital | 1.46e-08 | 224 | 65 | 9 | CID000004737 | |
| Drug | AC1NUW3V | 1.83e-08 | 29 | 65 | 5 | CID005462126 | |
| Drug | rufinamide | 1.83e-08 | 29 | 65 | 5 | CID000129228 | |
| Drug | 0-ol | 1.97e-08 | 11 | 65 | 4 | CID000069892 | |
| Drug | J-ST | 1.97e-08 | 11 | 65 | 4 | CID005288655 | |
| Drug | sym 2206 | 1.97e-08 | 11 | 65 | 4 | CID005039877 | |
| Drug | YM872 | 1.97e-08 | 11 | 65 | 4 | CID000148200 | |
| Drug | BAPTA | CACNA1A CACNA1C CHRNA6 ZACN PTPN12 NTSR2 GRIA1 GRIA2 GRIA3 GRIA4 | 2.66e-08 | 324 | 65 | 10 | CID000104751 |
| Drug | C-X6 | 2.94e-08 | 12 | 65 | 4 | CID005288002 | |
| Drug | Atpa | 2.94e-08 | 12 | 65 | 4 | CID000002252 | |
| Drug | 1NaPP1 | 2.94e-08 | 12 | 65 | 4 | CID000004877 | |
| Drug | willardine | 3.08e-08 | 32 | 65 | 5 | CID000005123 | |
| Drug | D-CPPene | 4.23e-08 | 34 | 65 | 5 | CID006435801 | |
| Drug | Naspm | 4.24e-08 | 13 | 65 | 4 | CID000129695 | |
| Drug | AC1Q3ZOL | 4.93e-08 | 258 | 65 | 9 | CID000002376 | |
| Drug | PhTX-343 | 5.71e-08 | 36 | 65 | 5 | CID000159548 | |
| Drug | quinoxaline-2,3-dione | 5.93e-08 | 14 | 65 | 4 | CID011469229 | |
| Drug | CGS 19755 | 7.57e-08 | 38 | 65 | 5 | CID000068736 | |
| Drug | pimozide | 7.57e-08 | 127 | 65 | 7 | CID000016362 | |
| Drug | thiokynurenic acid | 8.06e-08 | 15 | 65 | 4 | CID003035667 | |
| Drug | 3-isoxazolol | 8.87e-08 | 4 | 65 | 3 | CID009964065 | |
| Drug | sunifiram | 8.87e-08 | 4 | 65 | 3 | CID004223812 | |
| Drug | 4-(chloromethyl)-3-methoxy-5-methylisoxazole | 8.87e-08 | 4 | 65 | 3 | CID011105661 | |
| Drug | GTP[S] | CACNA1A CACNA1C HTR2C AVPR1B AVPR2 SCN3A SCN4A CACNA1H GCGR OPRD1 AGAP3 TPCN1 | 9.62e-08 | 591 | 65 | 12 | CID000001764 |
| Drug | gadolinium | 9.75e-08 | 199 | 65 | 8 | CID000023982 | |
| Drug | LY233536 | 1.07e-07 | 16 | 65 | 4 | CID000126239 | |
| Drug | repinotan | 1.07e-07 | 16 | 65 | 4 | CID000198756 | |
| Drug | amphetamine | 1.12e-07 | 284 | 65 | 9 | CID000003007 | |
| Drug | potassium | CACNA1A GPR89B CACNA1C CHRNA6 ZACN HTR2C CLCN6 KCNC3 ABCC8 SCN3A SCN4A CACNA1H KCNB2 SLC5A1 TPCN1 | 1.15e-07 | 1008 | 65 | 15 | CID000000813 |
| Drug | QX-314 | 1.26e-07 | 82 | 65 | 6 | CID000003925 | |
| Drug | verapamil | CACNA1A CACNA1C CHRNA6 KCNC3 SLC22A3 SCN3A SCN4A CILK1 CACNA1H KCNB2 TPCN1 | 1.29e-07 | 490 | 65 | 11 | CID000002520 |
| Drug | 7-Cl-Thio-Kyna | 1.40e-07 | 17 | 65 | 4 | CID003035668 | |
| Drug | PPNDS | 1.40e-07 | 17 | 65 | 4 | CID005961627 | |
| Drug | indoxyl-beta-D-glucoside | 1.40e-07 | 17 | 65 | 4 | CID000092769 | |
| Drug | LY 171555 | 1.63e-07 | 142 | 65 | 7 | CID000001257 | |
| Drug | haloperidol | CACNA1A CACNA1C HTR2C ABCC8 NTSR2 GRIA1 GRIA2 GRIA3 GRIA4 OPRD1 | 1.65e-07 | 394 | 65 | 10 | CID000003559 |
| Drug | MNQX | 1.80e-07 | 18 | 65 | 4 | CID000130818 | |
| Drug | philanthotoxin | 1.81e-07 | 45 | 65 | 5 | CID000115201 | |
| Drug | 7-chlorokynurenic acid | 1.81e-07 | 45 | 65 | 5 | CID000001884 | |
| Drug | LY382884 | 2.27e-07 | 19 | 65 | 4 | CID000656723 | |
| Drug | procaine | 2.71e-07 | 153 | 65 | 7 | CID000004914 | |
| Drug | IDRA 21 | 2.83e-07 | 20 | 65 | 4 | CID000003688 | |
| Drug | AC1N8N2J | 2.83e-07 | 20 | 65 | 4 | CID004346372 | |
| Drug | AC1L1FA8 | 3.11e-07 | 50 | 65 | 5 | CID000003150 | |
| Drug | M100907 | 3.44e-07 | 51 | 65 | 5 | CID000060858 | |
| Drug | CX546 | 3.49e-07 | 21 | 65 | 4 | CID000002890 | |
| Drug | AC1L1B62 | 3.49e-07 | 21 | 65 | 4 | CID000001299 | |
| Drug | lacosamide | 3.80e-07 | 52 | 65 | 5 | CID000219078 | |
| Drug | isradipine | 4.13e-07 | 100 | 65 | 6 | CID000003784 | |
| Drug | Fe-mo-s Cluster | 4.26e-07 | 22 | 65 | 4 | CID000445682 | |
| Drug | CX516 | 4.26e-07 | 22 | 65 | 4 | CID000148184 | |
| Drug | 13-methoxyibogamine | 4.60e-07 | 54 | 65 | 5 | CID000065749 | |
| Drug | cyclothiazide | 4.92e-07 | 103 | 65 | 6 | CID000002910 | |
| Drug | loperamide | 5.52e-07 | 105 | 65 | 6 | CID000003954 | |
| Drug | ethanol | CACNA1C CHRNA6 MGST2 SCN3A SCN4A FSHR GRIA1 GRIA2 GRIA3 GRIA4 GCGR SLC5A8 OPRD1 | 5.71e-07 | 837 | 65 | 13 | CID000000702 |
| Drug | pyraclofos | 5.84e-07 | 106 | 65 | 6 | CID000093460 | |
| Drug | CGP 39653 | 6.16e-07 | 24 | 65 | 4 | CID006437837 | |
| Drug | pD 8 | 6.16e-07 | 24 | 65 | 4 | CID000656948 | |
| Drug | GYKI 52466 | 6.61e-07 | 58 | 65 | 5 | CID000003538 | |
| Drug | Ns102 | 7.31e-07 | 25 | 65 | 4 | CID005311098 | |
| Drug | 2H-1,2,4-benzothiadiazine | 7.71e-07 | 7 | 65 | 3 | CID000473368 | |
| Drug | ketamine | 7.91e-07 | 262 | 65 | 8 | CID000003821 | |
| Drug | picrotoxin | 8.43e-07 | 181 | 65 | 7 | CID000031304 | |
| Disease | Bipolar Disorder | CACNA1A CACNA1C CHRNA6 ADRA2C HTR2C THSD7A AVPR1B IMPACT GRIA1 GRIA2 GRIA3 | 6.04e-09 | 477 | 64 | 11 | C0005586 |
| Disease | central nervous system disease (implicated_via_orthology) | 3.59e-08 | 16 | 64 | 4 | DOID:331 (implicated_via_orthology) | |
| Disease | Withdrawal Symptoms | 1.72e-07 | 58 | 64 | 5 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 1.72e-07 | 58 | 64 | 5 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 1.72e-07 | 58 | 64 | 5 | C0038587 | |
| Disease | Hyperkinesia, Generalized | 4.61e-05 | 32 | 64 | 3 | C0751217 | |
| Disease | Hyperkinesia | 4.61e-05 | 32 | 64 | 3 | C3887506 | |
| Disease | Hypoactive Sexual Desire Disorder | 6.91e-05 | 6 | 64 | 2 | C0020594 | |
| Disease | Sexual Arousal Disorder | 6.91e-05 | 6 | 64 | 2 | C0036902 | |
| Disease | Frigidity | 6.91e-05 | 6 | 64 | 2 | C0016722 | |
| Disease | Psychosexual Disorders | 6.91e-05 | 6 | 64 | 2 | C0033953 | |
| Disease | Orgasmic Disorder | 6.91e-05 | 6 | 64 | 2 | C0029261 | |
| Disease | Childhood Absence Epilepsy | 9.66e-05 | 7 | 64 | 2 | C4281785 | |
| Disease | Epilepsy, Minor | 9.66e-05 | 7 | 64 | 2 | C4552765 | |
| Disease | Absence Epilepsy | 9.66e-05 | 7 | 64 | 2 | C0014553 | |
| Disease | Akinetic Petit Mal | 9.66e-05 | 7 | 64 | 2 | C0001890 | |
| Disease | Epilepsy, Absence, Atypical | 9.66e-05 | 7 | 64 | 2 | C0751124 | |
| Disease | Absence Seizure Disorder | 9.66e-05 | 7 | 64 | 2 | C4553705 | |
| Disease | Juvenile Absence Epilepsy | 9.66e-05 | 7 | 64 | 2 | C4317339 | |
| Disease | Drug habituation | 1.16e-04 | 115 | 64 | 4 | C0013170 | |
| Disease | Substance-Related Disorders | 1.16e-04 | 115 | 64 | 4 | C0236969 | |
| Disease | Drug abuse | 1.16e-04 | 115 | 64 | 4 | C0013146 | |
| Disease | Drug Use Disorders | 1.16e-04 | 115 | 64 | 4 | C0013222 | |
| Disease | Drug Dependence | 1.16e-04 | 115 | 64 | 4 | C1510472 | |
| Disease | Substance Dependence | 1.16e-04 | 115 | 64 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 1.16e-04 | 115 | 64 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.16e-04 | 115 | 64 | 4 | C0029231 | |
| Disease | Prescription Drug Abuse | 1.16e-04 | 115 | 64 | 4 | C4316881 | |
| Disease | Substance abuse problem | 1.20e-04 | 116 | 64 | 4 | C0740858 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 2.06e-04 | 10 | 64 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 2.06e-04 | 10 | 64 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | body mass index, osteoarthritis | 2.23e-04 | 54 | 64 | 3 | EFO_0004340, MONDO_0005178 | |
| Disease | Mental Depression | 2.29e-04 | 254 | 64 | 5 | C0011570 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 2.83e-04 | 145 | 64 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 3.01e-04 | 12 | 64 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | extrapulmonary tuberculosis | 3.01e-04 | 12 | 64 | 2 | MONDO_0000368 | |
| Disease | Depressive disorder | 4.14e-04 | 289 | 64 | 5 | C0011581 | |
| Disease | Mood Disorders | 4.94e-04 | 168 | 64 | 4 | C0525045 | |
| Disease | anxiety disorder (implicated_via_orthology) | 1.04e-03 | 22 | 64 | 2 | DOID:2030 (implicated_via_orthology) | |
| Disease | Ovarian Serous Adenocarcinoma | 1.14e-03 | 23 | 64 | 2 | C1335177 | |
| Disease | Neonatal diabetes mellitus | 1.35e-03 | 25 | 64 | 2 | C0158981 | |
| Disease | status epilepticus (biomarker_via_orthology) | 1.35e-03 | 100 | 64 | 3 | DOID:1824 (biomarker_via_orthology) | |
| Disease | bipolar disorder (is_implicated_in) | 1.81e-03 | 29 | 64 | 2 | DOID:3312 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VFQCITMEGWTDLLY | 311 | O00555 | |
| MANVVFTQLLIWYGV | 796 | Q96P47 | |
| TFVLAVVMGVFVLCW | 381 | P18825 | |
| KVLGIVFFVFLIMWC | 311 | P28335 | |
| MEKLLNVFVWIGYVC | 346 | P28335 | |
| METIWIYQFRLIVIG | 1 | Q14964 | |
| MEAIWLYQFRLIVIG | 1 | Q96DA2 | |
| KLCAMLVVVLYAWGV | 141 | Q8NGK9 | |
| TKMLFVLVVVFGICW | 296 | Q9HB89 | |
| EFVNGWYIMIIISDI | 336 | Q8TDD5 | |
| VQVLRAIVVMYVICW | 296 | O95665 | |
| IWMCIVFAYIGVSVV | 546 | P42262 | |
| WMCIVFAYIGVSVVL | 556 | P42263 | |
| EIWMCIVFAYIGVSV | 546 | P48058 | |
| VMWFEKLYAGLQCVE | 1131 | Q9H6A9 | |
| DVWAVGCILYQMATL | 711 | Q6ZWH5 | |
| GCIIQLYVYMWLGSV | 96 | Q9Y3N9 | |
| WFASVYIVCQLMEDL | 216 | A6NFY4 | |
| MQYGIVANYCWLLVE | 231 | P47871 | |
| IEAMAAIYGEEWCVI | 16 | Q9P2X3 | |
| WAMGIILYEFLVGCV | 571 | Q9Y2H9 | |
| RMVLVVVGAFVVCWA | 261 | P41143 | |
| MVVDRVFLWVFIIVC | 461 | Q15825 | |
| YEAVKWMVVFAIGVC | 76 | P51797 | |
| EWFVIVIMATICFIL | 341 | Q01344 | |
| VEAVCIAWFTMEYLL | 236 | Q92953 | |
| VDCWAIGVIMYILLS | 201 | Q8NCB2 | |
| VFQCITMEGWTDVLY | 356 | Q13936 | |
| LTMVWVLGVIVRYCV | 141 | Q53EU6 | |
| YCVWKIFMATINIVF | 296 | B7ZAQ6 | |
| YCVWKIFMATINIVF | 296 | P0CG08 | |
| GVIQLWDYRMCTLID | 31 | P53621 | |
| YTDYLQTVICILEMW | 26 | Q9HBE5 | |
| CEDIMGYNILRVLIW | 356 | P23945 | |
| AYEIWMCIVFAYIGV | 536 | P42261 | |
| IFQVITLEGWVDIMY | 371 | O95180 | |
| AVYIMDTVGNIWVCY | 376 | O60779 | |
| GTWMTCYVIVTEIVG | 221 | O75751 | |
| CVEFYPIFIITLWMA | 56 | Q99735 | |
| VCLIFWLIFSIMGVN | 1166 | P35499 | |
| VIVVICLMFYALLWE | 21 | Q9NV12 | |
| YWDIQIGYQTREVMC | 316 | Q9UPZ6 | |
| IWEYNVVIIVMACRE | 121 | Q05209 | |
| IWVLVMYLGQCTKDI | 166 | Q9BX95 | |
| VIVIYFLVVMAVGLW | 31 | Q9NY91 | |
| VVWDYVVFAGMLVIS | 11 | Q8N695 | |
| VCLIFWLIFSIMGVN | 1341 | Q9NY46 | |
| WAVVYMCVIRGIETT | 191 | Q96N87 | |
| WLEVRMEYIGACVVL | 1246 | Q09428 | |
| IDVWAVGCIMAEVYT | 181 | Q9UPZ9 | |
| ILFNMVVGIVYIFCW | 416 | Q5GH73 | |
| VVGIVYIFCWFNVKE | 421 | Q5GH73 | |
| KMTFVIVLAYIACWA | 281 | P47901 | |
| NMVVGIIYIFCWFNV | 361 | Q5GH72 | |
| IVFDMVVGIIYIFSW | 431 | Q5GH76 | |
| WVGQCALYIVIMIFE | 151 | Q86TL2 | |
| CMGLIVFVWLYNIVL | 16 | Q8IVQ6 | |
| FMYLVVAVNGVWILV | 446 | Q9ULQ1 | |
| VGVLCTQFVFAGIWM | 376 | Q401N2 | |
| WMCVEDIYANIFIIK | 2136 | Q92508 | |
| IIVIYFVVVMAVGLW | 31 | P13866 | |
| CWHYAVTIVIVGMNY | 226 | Q9NWC5 | |
| VTIVIVGMNYAFITW | 231 | Q9NWC5 | |
| CIAIGGMFYVITWQT | 816 | Q15849 | |
| GVIAFMVNLSIYWII | 231 | Q7Z769 | |
| VCYKMGVLVVLTVLW | 21 | Q9NYU2 | |
| RMTLVIVVVYVLCWA | 271 | P30518 | |
| VEGVCVVWFTFEFLM | 351 | Q14003 | |
| DGFMVFCLWVSLVLQ | 111 | Q8IZF0 |